<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<!--
-->
<!-- %html{'xmlns'=>'http://www.w3.org/1999/xhtml', 'xml:lang'=>'en', 'lang'=>'en'} -->
<html>
<head>
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"d64d3db899","applicationID":"125361","transactionName":"dAkNQBFbXFUEREkBCVQTDlENQB9dDlUTCANZEkxHC1tH","queueTime":0,"applicationTime":970,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-298.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info,b=m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://";if(a&&a.agent&&a.licenseKey&&a.applicationID){f("mark",["onload",e()]);var c=h.createElement("script");c.src=b+a.agent,h.body.appendChild(c)}}function d(){"complete"===h.readyState&&f("mark",["domContent",e()])}function e(){return(new Date).getTime()}var f=a("handle"),g=window,h=g.document,i="readystatechange",j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:e(),origin:l};h[j]?(h[j](i,d,!1),g[j]("load",c,!1)):(h[k]("on"+i,d),g[k]("onload",c)),f("mark",["firstbyte",e()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
<title>
Planned Parenthood Southwest Ohio Region v. DeWine, 696 F.3d 490 (6th Cir. 2012), Court Opinion - Bloomberg Law 

</title>
<meta content='NOINDEX, NOFOLLOW' name='ROBOTS'>
<meta content='telephone=no' name='format-detection'>
<meta content='BLAW' name='apple-mobile-web-app-title'>
<meta name="csrf-param" content="authenticity_token"/>
<meta name="csrf-token" content="NiJ+70&#47;qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA="/>
<script src="/min_assets/framework.js?1389213936" type="text/javascript"></script>

<script src="/javascripts/daterange.js?1380743058" type="text/javascript"></script>
<script src="/javascripts/document/document.js?1382459272" type="text/javascript"></script>
<script src="/javascripts/document/document_viewer.js?1383685414" type="text/javascript"></script>
<script src="/javascripts/document/bciteutils.js?1388683076" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.query.js?1342203941" type="text/javascript"></script>
<script src="/javascripts/browser/browser.js?1387565892" type="text/javascript"></script>
<script src="/javascripts/document/image_viewer.js?1366129555" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.selection.js?1375450295" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.bb-copywithcitation.js?1383771008" type="text/javascript"></script>
<script src="/javascripts/document/copy_with_cite.js?1382560939" type="text/javascript"></script>
<script src="/javascripts/document/notepad.js?1366310522" type="text/javascript"></script>

<link href="/stylesheets/yui2/yui2_combo.css?1288273584" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_v2.css?1391022004" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/min_assets/framework.css?1391022047" media="screen,print" rel="stylesheet" type="text/css" />
<!--[if IE]>
<link href="/stylesheets/ie.css?1391022010" media="screen,print" rel="stylesheet" type="text/css" />
<![endif]-->
<link href="/stylesheets/search/search_results.css?1391022036" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document.css?1391022003" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_viewer.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/search/tree_view.css?1391022037" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/browser/browser_enhanced.css?1391021984" media="print,screen" rel="stylesheet" type="text/css" />
<style type='text/css'>
#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6 { font-family:Times New Roman, Times, serif; }
				#content_document pre {
				white-space: pre-wrap;
				white-space: -moz-pre-wrap;
				white-space: -pre-wrap;
				white-space: -o-pre-wrap;
				word-wrap: break-word;
				font-family: Bloomberg Fixed 2 Unicode;
			}
			
			#content_document .page_no { 
				font-weight:bold;
				text-decoration:none;
			}
			
			#content_document .highlight { 
				font-weight:bold; 
				background-color:yellow; 
				color:black;
			}
			
			#content_document .bcitehi { 
				font-weight:bold; 
				background-color:violet; 
				color:black;
			}
			
			/*.UNICODE {
			}
			
			#content_document blockquote {
			}
			
			#content_document em {
			}   
			
			#content_document .tableofcontents {
			}
			
			#content_document div.blockgroup {
			}
			
			#content_document p.opinion_text {
			}  */
			
			#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6, #content_document p, #content_document li, #content_document td, #content_document th, #content_document div {
				font-size: 11pt;
			}
			
			#content_document .main {
				text-align:center; 
				font-weight:bold; 
				color:black;
			}
			
			#content_document .ftnote { 
				font-style:italic;
			}
			
			#content_document .headline {
				font-weight:bold; 
				color:black;
			} 
			
			#content_document p.group{
				padding-top: 0; 
				padding-bottom: 1px; 
				padding-left: 0; 
				padding-right: 0;
				margin-top: 0; 
				margin-bottom: 1px; 
				margin-left: 0; 
				margin-right: 0;
			}
			
			#content_document .big {
				font-size: 13pt;
			}
			
			#content_document .indent {
				text-indent:2.5em;
			}
			
			#content_document .level2 {
				margin-left:2.5em;
				margin-right:2.5em;
			} 
			
			#content_document .level3 {
				margin-left:5em;
				margin-right:5em;
			} 					
			
			#content_document .level4 {
				margin-left:7.5em;
				margin-right:7.5em;
			} 					
			
			#content_document .level5 {
				margin-left:10em;
				margin-right:10em;
			} 					
			
			#content_document .level6 {
				margin-left:12.5em;
			} 					
			
			#content_document a.sup {
				font-size: 6pt; 
				vertical-align: top;
			}
			
			#content_document a.sup1 {
				font-size: 8pt; 
				vertical-align: top;
			}
			
			#content_document em.italic {
				font-style: italic;
			}
			
			#content_document em.bold {
				font-weight: bold;
				font-style: normal;
			}
			
			#content_document em.bold-big {
				font-size: 13pt; 
				font-weight: bold;
			}
			
			#content_document em.underline {
				font-style:normal; 
				text-decoration: underline;
			}
			
			#content_document em.bold-ital {
				font-weight: bold; 
				font-style: italic;
			}
			
			#content_document em.bold-underline {
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.ital-underline {
				font-style: italic; 
				text-decoration: underline;
			}
			
			#content_document em.ital-bold-underline { 
				font-style: italic; 
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document em.strike {
				font-style: normal;
				text-decoration: line-through;
			}
			
			#content_document .small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document h1.organization {
				font-weight: bold; 
				text-align:center; 
				font-style: normal;
			} 
			
			#content_document h2.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:2.5em; 
				margin-right:2.5em;
			}
			
			#content_document h3.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:5em; 
				margin-right:5em;
			}
			
			#content_document h4.organization {
				font-weight: bold;
				text-align:left;
				margin-left:7.5em; 
				margin-right:5em;
			}
			
			#content_document h5.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:10em; 
				margin-right:5em;
			}
			
			#content_document h2.citation {
				font-weight: bold; 
				text-align:left;
			}
			
			#content_document div.blcitation {
				font-size: 7pt; 
				text-align:center;
			}
			
			#content_document .italic {
				font-style:italic;
			}	
			
			#content_document ul.dash {
				list-style-type: none;
			}
			
			#content_document ul.bullet {
				list-style-type: disc;
			}
			
			#content_document ul.none {
				list-style-type: none;
			}
			
			#content_document li.off {
				list-style-type: none; 
			}
			
			#content_document .mypre { 
				font-size: 100%;
			}
			
			#content_document .TOC {
				text-align:left;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}
			
			#content_document .TOC hr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .bluehr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 500;
				text-align: center;
			}
			
			#content_document .tocentry {
				text-indent:-18px;
				padding-left:18px;
				color: #003399;
				font-weight: 700;
			}
			
			#content_document .doctext {  
				margin:0 auto;  
				text-align: left;  
			}				 
			
			#content_document span.PAGE { 
				color: black; 
				font-weight: bold 
			}
			
			#content_document a:link {  	
				color: #003399;  
				font-weight: 700;
			}
			
			#content_document a:visited {  
				color: #660066;   
				font-weight: 700;
			}
			
			#content_document .fn{  
				padding-left: 50 px; 
				font-weight: 550;
			}				
			
			#content_document .fr a:link {  
				color: #003399;  
				font-weight: 600;
			}
			
			#content_document .fr a:visited {  
				color: #660066;  
				font-weight: 600;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 600;
				text-align: center;
			}
			
			#content_document .volume {  
				text-align:center;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}				
			
			#content_document h2.blcitation {
				font-size: 7pt; 
				text-align:center; 
				white-space:nowrap;
			}
			
			#content_document cite.blcitation {
				white-space:nowrap;
			}
			
			#content_document table.page_legend { 
					width: 100px; 
					text-align: left; 
					background-color: white; 
					font-family: Bloomberg Proportional Unicode;
					font-size: 12px
			}
			#content_document div.page_text {  padding-left: 50 px; margin:0 0 0 50px;  text-align: center;  width:100px; font-size: 12px}

			#content_document .smalllinks{  text-align: right;  font-size: 10px;  font-weight: 500;}		
			
			#content_document .opinion_headnotes{
				margin-top:6px;
				margin-bottom:6px;
			}
			
			#content_document .headnote_group{
				padding: 10px 10px 2px 10px;
				background-color: #ECECEC;
				margin-top:4px;
				margin-bottom:10px;
			}
			
			#content_document .headnote_group_header{
				font-weight: bold;
				margin-bottom: 8px;
			}
			
			#content_document .opinion_headnote{
				clear:both;
				padding-bottom: 4px;
				margin-bottom:10px;
			}
			
			#content_document .highlighted_headnote{
				background-color: #FFFF22;
			}
			
			#content_document .headnote_link{
				font-weight:bold;
				text-decoration: none;
			}
			
			#content_document .show_hide_headnotes{
			}
			
			#content_document .clearfix:after {
				clear:both;
				content: ".";
				height:0px;
				display:block;
				visibility:hidden;
			}
			
			/* BNA Headnotes */
			
			#content_document .headnotesContainer {
				margin: 12px 0;
				padding: 12px 0;
				border-top: 1px solid #000;
				border-bottom: 1px solid #000;
			}
			
			#content_document .headnotesContainer .headnotesContainerTitle {
				font-size: 16px;
				font-weight: bold;
				text-align: center;
			}
			
			#content_document .headnotesContainer .headnoteTitle {
				padding: 8px 12px;
				background-color: #dedede;
				margin: 24px 0 0 0;
				font-size: 16px;
				font-weight: bold;
				text-transform: uppercase;
			}
			
			#content_document .headnotesContainer .headnote {
				margin-left: 24px;
			}
			
			#content_document .headnotesContainer .headnote .headnoteSlug {
				margin-top: 12px;
				font-size: 16px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteDescriptor {
				margin-top: 12px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteToggle .headnoteText {
				margin-bottom: 12px;
			}
		
</style>
<link href="/stylesheets/yui_calendar.css?1391022047" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/docviewer_overrides.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />

<link href="/stylesheets/print.css?1391022029" media="print" rel="stylesheet" type="text/css" />
<link href='/images/favicon.ico' rel='shortcut icon'>
</head>
<body class='securities  document '>
<div class='container'>
<div id='page_loader'></div>
<div class='printHeader printOnly'>
<img src='/images/print_header.jpg'>
<div class='user'>
<span>
Prepared for: Susan Yeh
</span>
</div>
</div>
<div class='topBarHolder printHide'>
<div class='topBar'>
<ul class='topBarElements'>
<li class='skip'>
<a href="#primary_content" tabindex="1">Skip Navigation</a>
</li>
<li class='logout'>
<a href="/log_out.htm" id="logoutButton" onclick="generateExplicitLogoutEvent();">Logout</a>
</li>
<li id='help'>
<a href="/help" target="_blank">Help</a>

</li>
<li id='user'>
<a href="/settings">Susan Yeh</a>

</li>
<li class='withNotifications' id='client_matter'>
<div class='clientMatterDropDown'>
<div>Client Matter</div>
<div class='skinButton blueAlert' style='display:none'>
<span id='currentClientMatter'>

</span>
</div>
<span class='noneSelected' style=''>
&nbsp;(None Selected)
</span>
<div class='expandable'></div>
</div>
<div class='topNavDropdown' id='sub_client_matter'>
<ul>
<li style='display:none'>
<a class='remove_client_matter_menu_item' href='#' onclick='return true;' title='Remove Current Client Matter'>
Remove Current Client Matter
</a>
</li>
<li>
<a class='enter_client_matter_menu_item' href='#' onclick='return true;' title='Enter Client Matter'>
Enter Client Matter
</a>
</li>
</ul>
</div>

</li>
<li class='withNotifications' id='alerts'>
<a href="/alerts/inbox"><div id='unreadAlertsCount'>
Saved Searches & Alerts
</div>
</a>
</li>
<li class='withNotifications' id='downloads'>
<a href="/download/download_center"><div id='unreadDownloadsCount'>
<div>Downloads</div>
</div>
</a>
</li>
<li id='research_trail'>
<a href="/research_trail"><div>Research Trail</div>
</a>
</li>
<li id='workspaces'>
<a href="/workspaces"><div>Workspaces</div>

</a></li>
</ul>
</div>
</div>

<div class='topMenu textBkDark printHide' id='top_menu'>
<div class='contextHolder'>
<a href='/home'>
<h1 class='logo'></h1>
</a>
<div class='menuRow'>
<ul class='menuItems'>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_HOME' onclick="javascript:navigation_selectMenuItem('HOME');">
Home
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button active' id='nav_menu_button_search' onclick="javascript:navigation_selectMenuItem('search');">
Search & Browse
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_practice_areas' onclick="javascript:navigation_selectMenuItem('practice_areas');">
Practice Centers
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LITIGATION' onclick="javascript:navigation_selectMenuItem('LITIGATION');">
Litigation & Dockets
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_transactional' onclick="javascript:navigation_selectMenuItem('transactional');">
Transactional Law
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LEG_REG' onclick="javascript:navigation_selectMenuItem('LEG_REG');">
Legislative & Regulatory
</a>
</li>
<li class='legalAnalysis' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_news' onclick="javascript:navigation_selectMenuItem('news');">
Legal Analysis & News
</a>
</li>
<li class='last' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_market' onclick="javascript:navigation_selectMenuItem('market');">
Companies & Markets
</a>
</li>

</ul>
</div>
<form accept-charset="UTF-8" action="/autocomplete/jump" id="search_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id='quicksearch_context' name='context_value' type='hidden' value='PRACTICE'>
<div class='searchBox' id='quick_search'>
<div class='inputContainer'>
<input autocomplete='off' id='quick_search_term' name='term' onkeydown='framework_handleTextInput(event,quick_search_term)' tabindex='2' type='text'>
<div class='searchButton' onmouseup='return framework_activateForm();' tabindex='3'></div>
<a href="/help/BLAWHelpSystem.htm#GO_Using_the_GO_BAR.htm" class="infoBtn" target="_blank" title="Using the &lt;GO&gt; Bar"></a>
<input id='quick_search_post' name='qs_type' type='hidden' value='general'>
<input id='quick_search_type' name='type' type='hidden' value='input_terms'>
<input id='quick_search_value' name='item_value' type='hidden'>
<input id='quick_search_origin' name='search_type' type='hidden' value='LAW'>
</div>
</div>
</form>


</div>
</div>

<div class='main clearfix'>
<div class='menuDrawer'>
<div class='interior'>
<div class='drawer_shade drawerShade clearfix'>
<div class='dropShadow'></div>
<div class='sub_menu subMenu' id='sub_menu_HOME'>
<table>
<tr>
<td class=''>
<ul>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_search'>
<div class='subTitles'>
<div class='subItem one '>
Search
</div>
<div class='subItem two '>
Specialized Searches
</div>
<div class='subItem one last'>
Browse
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/legal_search'>
<div class='navLinkTitle'>
All Legal Content
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Court Opinions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dnds_search'>
<div class='navLinkTitle'>
Domain Name Decisions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
News
</div>
</a>
</li>
<li>
<a class='clearfix' href='/patent_search'>
<div class='navLinkTitle'>
Patents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/people_search'>
<div class='navLinkTitle'>
People
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Regulatory
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/no_action_search'>
<div class='navLinkTitle'>
SEC No-Action Letters
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.293113'>
<div class='navLinkTitle'>
Federal Law
</div>
</a>
</li>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Law
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_practice_areas'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/antitrust'>
<div class='navLinkTitle'>
Antitrust
</div>
</a>
</li>
<li>
<a class='clearfix' href='/banking_finance'>
<div class='navLinkTitle'>
Banking & Finance
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/bankruptcy'>
<div class='navLinkTitle'>
Bankruptcy
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/corporate_ma'>
<div class='navLinkTitle'>
Corporate/M&A
</div>
</a>
</li>
<li>
<a class='clearfix' href='/employee_benefits'>
<div class='navLinkTitle'>
Employee Benefits
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/health'>
<div class='navLinkTitle'>
Health
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/ip_law'>
<div class='navLinkTitle'>
Intellectual Property
</div>
</a>
</li>
<li>
<a class='clearfix' href='/labor_employment'>
<div class='navLinkTitle'>
Labor & Employment
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/securities'>
<div class='navLinkTitle'>
Securities
</div>
</a>
</li>
<li>
<a class='clearfix' href='/tax'>
<div class='navLinkTitle'>
Tax
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LITIGATION'>
<div class='subTitles'>
<div class='subItem two '>
Litigation
</div>
<div class='subItem two last'>
Dockets
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Search Court Opinions
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_menu/X7TO28O'>
<div class='navLinkTitle'>
BNA Outlines & Headnotes
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.103000'>
<div class='navLinkTitle'>
Federal Rules
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/general'>
<div class='navLinkTitle'>
Litigation Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Search Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/breaking'>
<div class='navLinkTitle'>
Breaking Complaints
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/analytics'>
<div class='navLinkTitle'>
Docket Analytics
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dockets/coverage'>
<div class='navLinkTitle'>
Docket Coverage
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/requests'>
<div class='navLinkTitle'>
Docket Requests
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/tracking'>
<div class='navLinkTitle'>
Docket Tracking
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_transactional'>
<div class='subTitles'>
<div class='subItem two '>
Search
</div>
<div class='subItem two last'>
Resources
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/example_and_saved_searches'>
<div class='navLinkTitle'>
Example Searches
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dealmaker_clause_search'>
<div class='navLinkTitle'>
DealMaker Clauses
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/deal_maker/current_awareness'>
<div class='navLinkTitle'>
Current Awareness
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_menu/X7TS80O'>
<div class='navLinkTitle'>
Drafting Guides & Overviews
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_menu/X7TVS0O'>
<div class='navLinkTitle'>
Transactional Legal Treatises
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/deal_maker/resources'>
<div class='navLinkTitle'>
Transactional Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LEG_REG'>
<div class='subTitles'>
<div class='subItem two '>
Legislative
</div>
<div class='subItem two last'>
Regulatory
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Search Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/leg_search/congressional_bill_search'>
<div class='navLinkTitle'>
Search Congressional Bills
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24221'>
<div class='navLinkTitle'>
U.S. Code
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Legislative Materials
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/leg_news_analysis'>
<div class='navLinkTitle'>
Legislative Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Search Regulatory
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search/federal_register_search'>
<div class='navLinkTitle'>
Search Federal Register
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24230'>
<div class='navLinkTitle'>
Code of Federal Regulations
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Regulatory Materials
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_updates'>
<div class='navLinkTitle'>
Monitor Regulators
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/reg_news_analysis'>
<div class='navLinkTitle'>
Regulatory Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_news'>
<div class='subTitles'>
<div class='subItem two '>
Legal Analysis
</div>
<div class='subItem two last'>
News
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
Search News
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/news'>
<div class='navLinkTitle'>
Legal News
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/news/topic'>
<div class='navLinkTitle'>
News by Topic
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/top_news'>
<div class='navLinkTitle'>
TOP News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_market'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/business_development'>
<div class='navLinkTitle'>
Business Development Center
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
Search EDGAR
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company'>
<div class='navLinkTitle'>
Company Watchlist
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li class='last'>
<a class='clearfix' href='/report_writer'>
<div class='navLinkTitle'>
Company Report Writer
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/market'>
<div class='navLinkTitle'>
Market News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>

</div>
</div>
<div class='bottomFlange'></div>
</div>
<div class='breadcrumbContainer printHide'>
<div class='breadHolder'>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_0'>
Search & Browse
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_1'>
<a href='/conversion/resolve_search/27097952869057ce1f291791b8f3f48d'>
Court Opinions
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_2'>
<a href='/opinion_search/results/27097952869057ce1f291791b8f3f48d'>
Search Results
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
</div>
</div>

</div>
<div class='page clearfix'>
<div class='content' id='page_content'>
<div id='statusHolder'></div>
<a name='primary_content'></a>
<div class='document_search_links_container printHide'>
<div class='prev_search_result_container'>
<div class='attachmentPanelBackButton' onclick="document.location = $('.prev_search_result_link a').attr('href')"></div>
<div class='prev_search_result_link'>
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X1II6TS003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1II6TS003">Previous Result: <span>Scentsy, Inc. v. B.R. Chase, LLC, Case N...</span></a>
<div class='clearfix'></div>
</div>
</div>
<div class='next_search_result_container'>
<div class='next_search_result_link'>
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X1II6UG003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1II6UG003">Next Result: <span>Central Laborers&#x27; Pension, Welfare &amp; Ann...</span></a>
<div class='clearfix'></div>
</div>
<div class='attachmentPanelForwardButton' onclick="document.location = $('.next_search_result_link a').attr('href')"></div>
</div>
<div class='clearfix'></div>
</div>
<div class='clearfix'></div>

<div class='breadCrumbTitleRow clearfix eight grid'>
<div class="icon citation distinguished" title="Distinguished"></div>
<div class='title left' title='Planned Parenthood Southwest Ohio Region v. DeWine, 696 F.3d 490 (6th Cir. 2012), Court Opinion'>
Planned Parenthood Southwest Ohio Region v. DeWine, 696 F.3d 490 (6th Cir. 2012), Court Opinion
</div>
</div>

<div class='metadata' style='display: none'>
<div class='documentTitle'>Planned Parenthood Southwest Ohio Region v. DeWine, 696 F.3d 490 (6th Cir. 2012), Court Opinion</div>
<div class='docId'>X1II4EC003</div>
<div class='docType'>OPINIONS</div>
<div class='case_name'>Planned Parenthood Southwest Ohio Region v. DeWine</div>
<div class='displayCitation'>2012 BL 254593</div>
<div class='displayCitation'>696 F.3d 490</div>
<div class='displayCitation'>bna a0d4x7k4y8</div>
<div class='displayCitation'>wkf6case:26511590</div>
</div>

<div class='search_outline_node_popup' style='display:none'>
<form accept-charset="UTF-8" action="/document/class_outline_search" id="search_document_node_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>Search</h2>
</div>
<p class='searchOver'>
Search over:
<span class='search_target_node'></span>
<input class="search_source_id" id="source_id" name="source_id" type="hidden" />
<input class="search_node_id" id="search_node_id" name="search_node_id" type="hidden" />
<input class="search_service_code" id="search_service_code" name="search_service_code" type="hidden" />
<input class="search_division" id="search_division" name="search_division" type="hidden" />
<input autocomplete="off" class="search_node_text" id="search_term" name="search_term" type="text" />
</p>
<div class='clearfix'></div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right print' onclick='this.form.submit();'>
<span>
Search
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

</div>
<div id='no_matching_keywords_popup' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>No Matches Found</h2>
</div>
<p>
Search term(s) not found.
</p>
<div class='popUpActions'>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>
<div id='copyWithCitationPopupContents' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>Copy with Citation</h2>
</div>
<p>
Copy the text below to paste into your document.
</p>
<div class='clearfix'>
<div class='copyWithCitationScrollBox'>
<div class='copyWithCitationArea left'>
<div class='copyWithCitationText'></div>
<div class='copyWithCitationDocumentTitle'></div>
</div>
<div class='ie9compat left'>
<img alt="" src="/images/transparency.png?1296705112" width="1" />
</div>
</div>
</div>
<div class='copyWithCitationCheckBoxHolder'>
<input checked="checked" class="linkCitation" id="link_citation" name="link_citation" onclick="updateCopyWithCitationLinks()" type="checkbox" value="true" />
Link citations to Bloomberg Law
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>

<script type='text/javascript'>
  //<![CDATA[
    $('#page_content').addClass("invisible");
  //]]>
</script>
<input id="doc_id" name="doc_id" type="hidden" value="X1II4EC003" />
<input id="hidden_document_title" name="hidden_document_title" type="hidden" value="Planned Parenthood Southwest Ohio Region v. DeWine, 696 F.3d 490 (6th Cir. 2012), Court Opinion" />
<input id="hidden_case_name" name="hidden_case_name" type="hidden" value="Planned Parenthood Southwest Ohio Region v. DeWine" />
<input id="hidden_case_docket" name="hidden_case_docket" type="hidden" />
<div class='toolHolder'>
<form accept-charset="UTF-8" action="" id="downloadPopupLinkForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div><input id="pde_location_type" name="pde_location_type" type="hidden" value="DOCUMENT" /><input id="full_doc_path" name="full_doc_path" type="hidden" value="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X1II4EC003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="document_type" name="document_type" type="hidden" value="OPINIONS" /><input id="doc_id" name="doc_id" type="hidden" value="X1II4EC003&amp;search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="artifact_id" name="artifact_id" type="hidden" value="X1II4EC003" /><input id="title" name="title" type="hidden" value="Planned Parenthood Southwest Ohio Region v. DeWine, 696 F.3d 490 (6th Cir. 2012), Court Opinion" /><input id="search32" name="search32" type="hidden" value="DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="citation_analysis" name="citation_analysis" type="hidden" value="DISTINGUISHED" /><input id="context_resource_id" name="context_resource_id" type="hidden" value="27097952869057ce1f291791b8f3f48d" /><input id="has_sidebar_info" name="has_sidebar_info" type="hidden" value="true" /><input id="tab_types_" name="tab_types[]" type="hidden" value="TAB_OPINION" /><input id="has_notepad" name="has_notepad" type="hidden" value="true" /><input id="notepad_id" name="notepad_id" type="hidden" value="X1II4EC003" /><input id="has_headnotes" name="has_headnotes" type="hidden" value="false" /><input id="preselect_option" name="preselect_option" type="hidden" value="DOCUMENT" /></form>

<ul class='tools printHide'>
<li>
<a href="#" onclick="javascript:quickPrintLink(); return false;">Quick Print</a>

</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('download','downloadPopupLinkForm'); return false;">Print/Download</a>
</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('email','downloadPopupLinkForm'); return false;">Email</a>
</li>
<li>
<a href="#" onclick="javascript:addPopupForm('add_to_workspace','?resource_path=%2Fs%2Fopinion%2F%32%37%30%39%37%39%35%32%38%36%39%30%35%37ce%31f%32%39%31%37%39%31b%38f%33f%34%38d%2Fdocument%2FX%31II%34EC%30%30%33%3Fsearch%33%32%3DDPNLUQBDE%31FN%30Q%33IC%35PMASPT%36%34TJMSRPDPNMSUBDECUJ%32&amp;document_type=OPINIONS', null); return false;">+ Workspace</a>
</li>
<li>
<a onclick='javascript:PDETray_default.addSelection();'>
+ Queue
</a>
</li>
<li class='last'></li>
</ul>
</div>

<div class='bootstrap printHide tabs'>
<a class='borderTab activeTab' id='tab_DOCUMENT'>
Document
</a>

<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/bcite/X1II4EC003/history" class="borderTab inactiveTab" id="tab_HISTORY" onclick="docTabSpinner()">Direct History</a>

<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/bcite/X1II4EC003/analysis" class="borderTab inactiveTab" id="tab_ANALYSIS" onclick="docTabSpinner()">Case Analysis</a>

<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/bcite/X1II4EC003/toa" class="borderTab inactiveTab" id="tab_TOA" onclick="docTabSpinner()">Table of Authorities</a>

<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/related_content/X1II4EC003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="borderTab inactiveTab" id="tab_CITING_DOCS" onclick="docTabSpinner()">Citing Documents</a>

<div class='showHide printHide'>
<div class='showHideSidebarArrow'>
<a class='bliderText' id='bliderLink'>
<span id='bliderText'>
Hide General Info & Notepad
</span>
<span id='notepadCountLabel'></span>
</a>
</div>
</div>

</div>

<!-- document -->
<script type='text/javascript'>
  //<![CDATA[
    var fluid_layout=false;
  //]]>
</script>

<!-- %table.markupContainment -->
<!-- %tbody -->
<!-- %tr -->
<!-- %td#markup_holder{:valign=>"top", :align=>"left"} -->
<div class='docHolder legal hasSearchTerms ' id='doc_holder'>
<div class='documentContent ' id='content_document'>


<script type="text/javascript">
					function Blaw__Citator()
					{
						window.location="bloomberg:bcite_url_prefix=/rest/documents/1737463562243";
					}
				</script><script type="text/javascript">
      var BLAW_TOTAL_KEYWORD = 0;
      var BLAW_CURRENT_KEYWORD = -1;
      var BLAW_LAST_COLOR = "yellow";
      var BLAW_ANCHOR_NAME = "blawkeyword";
      var BLAW_BASE_URL = document.location.href;

      function Blaw__changeCurElem(lastAnchor, newAnchor)
      {
        var baseUrl = Blaw__getBaseURL(document.location.href);
        document.location.href = baseUrl + "#" + newAnchor;
        var elem = document.getElementById(lastAnchor)[0];
        if (elem) {
          elem.style.backgroundColor = BLAW_LAST_COLOR;
        }
        elem = document.getElementById(newAnchor)[0];
        if (elem) {
          BLAW_LAST_COLOR = elem.style.backgroundColor;
          elem.style.backgroundColor = "orange";
        }
      }

      function Blaw__findNextKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (++BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }

        // if index does not exist on page continue to inc until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD < BLAW_TOTAL_KEYWORD) {
            ++BLAW_CURRENT_KEYWORD;
            // wrap around search, once only
            if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD && !looped) {
              BLAW_CURRENT_KEYWORD = 0;
              looped = true;
            }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findPrevKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (--BLAW_CURRENT_KEYWORD < 0) {
          BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
          looped = true;
        }

        // if index does not exist on page continue to decr until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD >= 0) {
          --BLAW_CURRENT_KEYWORD;
          // wrap around search, once only
          if (BLAW_CURRENT_KEYWORD < 0 && !looped) {
            BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
            looped = true;
          }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findNextFrom(indx)
      {
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        BLAW_CURRENT_KEYWORD = indx;
        ++BLAW_CURRENT_KEYWORD;
        if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__getBaseURL(url)
      {
        var reg = new RegExp("(.+)#.+$");
        var ar = reg.exec(url);
        if (ar != null) {
          return ar[1];
        } else {
          return url;
        }
      }


    </script><div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="metadata" style="display: none">
<div class="pagination_series_list">PrimaryFederalReporter,Bloomberg,</div>
<div class="citation-group">
<div class="cite" data-cite-type="PrimaryFederalReporter">696 F.3d 490</div>
<div class="cite" data-cite-type="DocketNumber">11-4062</div>
<div class="cite" data-cite-type="Bloomberg">2012 BL 254593</div>
</div>
</div>
<div align="left" class="tableofcontents">
<br CLEAR="right"><div class="page_text" style="float:right">
<b>Pagination</b><table class="page_legend" cellspacing="0">
<tr>
<td width="25%" align="left" valign="top">*</td>
<td width="50%" align="left" valign="top">F.3d </td>
</tr>
<tr>
<td width="25%" align="left" valign="top">**</td>
<td width="50%" align="left" valign="top">BL</td>
</tr>
</table>
</div>
<br>
</div>
<table><tbody><tr><td>&nbsp;</td></tr></tbody></table>
<p><center>
United States Court of Appeals, Sixth Circuit.
</center></p>
<hr align="center" width="65%">
<p><center>
PLANNED PARENTHOOD SOUTHWEST OHIO REGION; Planned Parenthood of Central
Ohio; Planned Parenthood of Northeast Ohio; Timothy Kress; Laszlo Sogor;
Preterm, Plaintiffs-Appellants, v. Mike DeWINE, Attorney General of Ohio;
Joseph Deters, Defendants-Appellees.
</center></p>
<hr align="center" width="65%">
<p><center>
No. 11-4062.
</center></p>
<p><center>
Argued: June 7, 2012.
</center></p>
<p><center>
Decided and Filed: October 2, 2012.
</center></p>
<div id="para2" printdualcolumn="true"><p>
Appeal from the United States District Court for the Southern District of
Ohio, Susan J. Dlott, Chief Judge.
<span CLASS="page_no" data-cite="696 f 3d 491" data-cite-type="PrimaryFederalReporter" data-cite-pageno="491" data-primary-citation="696 F.3d 490">[*491]</span> 
[EDITORS' NOTE: THIS PAGE CONTAINED HEADNOTES AND HEADNOTES ARE NOT AN
OFFICIAL PRODUCT OF THE COURT, THEREFORE THEY ARE NOT DISPLAYED.]
</p></div>
<div id="para2" printdualcolumn="true"><p>
<span CLASS="page_no" data-cite="696 f 3d 492" data-cite-type="PrimaryFederalReporter" data-cite-pageno="492" data-primary-citation="696 F.3d 490">[*492]</span> 
[EDITORS' NOTE: THIS PAGE CONTAINED HEADNOTES AND HEADNOTES ARE NOT AN
OFFICIAL PRODUCT OF THE COURT, THEREFORE THEY ARE NOT DISPLAYED.]
</p></div>
<div id="para2" printdualcolumn="true"><p>
<span CLASS="page_no" data-cite="696 f 3d 493" data-cite-type="PrimaryFederalReporter" data-cite-pageno="493" data-primary-citation="696 F.3d 490">[*493]</span> 
<b>ARGUED:</b> B. Jessie Hill, Case Western Reserve University School of Law,
Cleveland, OH, for Appellants. Jeannine R. Lesperance, Office of the Ohio
Attorney General, Columbus, OH, for Appellees. <b>ON BRIEF:</b> B. Jessie Hill,
Case Western Reserve University School of Law, Cleveland, OH, Helene T.
Krasnoff, Planned Parenthood Federation of America, Washington, D.C., Roger
K. Evans, Planned Parenthood Federation of America, New York, NY, Alphonse
A. Gerhardstein, Gerhardstein &amp; Branch Co. LPA, Cincinnati, OH, Carrie L.
Davis, for Appellants. Jeanhine R. Lesperance, Erick D. Gale, Office of the
Ohio Attorney General, Columbus, OH, for Appellees. Mailee R. Smith,
Americans United For Life, Washington, D.C., for Amici Curiae.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Before: MOORE, ROGERS, and McKEAGUE, Circuit Judges.
</p></div>
<div id="contentOpinion" printdualcolumn="true"><div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>OPINION</b>
</p></div></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  KAREN NELSON MOORE, Circuit Judge.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  MOORE, J., delivered the opinion of the court in which, ROGERS and
McKEAGUE, JJ., joined in Parts I-V. MOORE, J. (pp. 507-13), delivered a
separate Part VI, which dissents in part from the separate majority opinion
delivered by McKEAGUE, J. (pp. 513-18), with which, ROGERS, J., concurs.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In 2004, Ohio passed a law criminalizing the distribution of mifepristone,
also known as RU-486, unless the distribution mirrored certain protocols and
gestational time limits identified by the FDA when mifepristone was first
approved in 2000. Ohio Rev.Code &sect; <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X4OGMFG5GVG0?jcsearch=Ohio%20Rev.%20Code%20%202919.123&amp;summary=yes#jcite">2919.123</a> (the "Act"). Mifepristone, in
combination with misoprostol, was the only form of medical abortion offered
by Planned Parenthood in Ohio. Planned Parenthood's Ohio regional clinics
and two of its doctors (collectively, "Planned Parenthood") brought suit
shortly
<span CLASS="page_no" data-cite="696 f 3d 494" data-cite-type="PrimaryFederalReporter" data-cite-pageno="494" data-primary-citation="696 F.3d 490">[*494]</span> 
after the Act's passage challenging its constitutionality on several
grounds. Although a preliminary injunction is in place to cover the Act's
failure to make an exception for circumstances involving the health and life
of the mother, the Act has otherwise been in force since February 2011.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The issue on this appeal is whether the district court erred in granting
summary judgment in favor of the defendants on three of the four
constitutional claims brought by Planned Parenthood facially challenging the
Act. Following the resolution of certain certified questions by the Ohio
Supreme Court, the district court held that (1) the Act was no longer
unconstitutionally vague, (2) the Act did not violate a woman's right to
bodily integrity under the <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=USCONST%20AMEND%20XIV&amp;summary=yes#jcite">Fourteenth Amendment</a>, and (3) the Act did not
impose an undue burden on a woman's <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X10V1Q8003?jcsearch=USCONST%20AMEND%20XIV&amp;summary=yes#jcite">Fourteenth Amendment</a> right to choose
<span CLASS="page_no" data-cite="2012 bl 254593 p 2" data-cite-type="Bloomberg" data-cite-pageno="2" data-primary-citation="">[**2]</span> abortion. The fourth claim, whether the Act unduly burdens a woman's right
to health and life under the Fourteenth Amendment, is being held for trial
and is not at issue on this appeal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Upon review, we unanimously <b>AFFIRM</b> the district court's grant of summary
judgment on Planned Parenthood's vagueness and bodily-integrity claims.
Judge McKeague joined by Judge Rogers <b>AFFIRM</b> the district court's judgment
in full. Judge Moore would reverse and remand on the undue-burden claim
regarding the right to choose. Thus, this opinion is the opinion of the
court with respect to all parts except Part VI, which is the opinion of
Judge Moore dissenting in part, and Judge McKeague's opinion constitutes the
opinion of the majority for Part VI. The judgment of the district court is
therefore <b>AFFIRMED.</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>I. BACKGROUND</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>A. Factual Background</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Before 2000, most first-trimester abortions were surgical, performed by a
procedure commonly known as vacuum aspiration or suction curettage. <i>Planned</i>
<i>Parenthood Cincinnati Region v. Taft</i><a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X14RLFG003?jcsearch=444%20f%203d%20502&amp;summary=yes#jcite">444 F.3d 502</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X14RLFG003?jcsearch=444%20f%203d%20502&amp;summary=yes#jcite">505</a> (6th Cir.2006) ("<i>Taft</i>
<i>II</i>"). The parties agree that surgical abortions in the first trimester are
extremely safe and, for most healthy women, can take less than five to ten
minutes at an outpatient clinic, usually with only local anesthesia and
often sedation. Briefly, a surgical abortion is performed by inserting a
speculum into the woman's vagina, dilating the cervix, and then inserting a
tube into her uterus that empties the contents by suction. Side effects
include bleeding and cramping. Surgical abortions have been performed for
decades, and the mortality rate is extremely low at roughly .1 per 100,000.
R. 144-1 (Paul Decl. &para;&para; 14-20), <i>as cited by</i> R. 139-1 (Defs.' Mot. to Strike
at 3 n. 1) <i>and</i> Appellee Br. at 5.<a HREF="#fn100" name="fnref_fn100">[fn1]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In 2000, the Food and Drug Administration ("FDA") first approved the
distribution and use of mifepristone in the United States. Mifepristone,
also called RU-486, is a medication that "terminates the pregnancy by
detaching the gestational sac from the uterine wall." <i>Taft II</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X14RLFG003?jcsearch=444%20f%203d%20502&amp;summary=yes#jcite">444 F.3d at 505</a> n. 1. Approximately 24 to 48 hours later, the woman takes a
second medication, misoprostol, which is "a prostaglandin which induces the
contractions necessary to expel the fetus and other products of conception
from the uterus." <i><a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X14RLFG003?jcsearch=444%20F.3d%20502&amp;summary=yes#jcite">Id</a>.</i><a HREF="#fn200" name="fnref_fn200">[fn2]</a> Side
<span CLASS="page_no" data-cite="696 f 3d 495" data-cite-type="PrimaryFederalReporter" data-cite-pageno="495" data-primary-citation="696 F.3d 490">[*495]</span> 
effects of the procedure include bleeding for an average of nine to sixteen
days and cramping and may also include fever, diarrhea, nausea, or vomiting.
Joint Appendix ("J.A.") at 255 (FDA Patient Information Sheet at 1).<a HREF="#fn300" name="fnref_fn300">[fn3]</a>
The parties agree that the mortality rate of mifepristone abortions is less
than 1 per 100,000, but they debate the significance of this number. R.
144-1 (Paul Decl. &para; 23), <i>as cited by</i> Appellee Br. at 5.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  A U.S. manufacturer first filed a New Drug Application for mifepristone in
1996. J.A. at 187 (FDA Approval Letter at 1). Consistent with the three
clinical trials submitted in support of the application, <i>see</i> J.A. at 192
(FDA Approved Labeling at 3), the "FDA labeling and approval letter
indicated that the appropriate treatment regimen was to administer 600 mg of
mifepristone orally followed by 0.4 mg of misoprostol administered orally
two days later and <span CLASS="page_no" data-cite="2012 bl 254593 p 3" data-cite-type="Bloomberg" data-cite-pageno="3" data-primary-citation="">[**3]</span> that mifepristone was not to be administered after
forty-nine days' gestation." <i>Taft II</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X14RLFG003?jcsearch=444%20f%203d%20502&amp;summary=yes#jcite">444 F.3d at 505</a>. The FDA approved
mifepristone's application under <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=21%20cfr%20pt%20314&amp;summary=yes#jcite">21 C.F.R. &sect; 314</a> Subpart H, and imposed
eight heightened restrictions on the post-approval distribution of the drug
to "assure safe use." <i>See</i> J.A. at 188 (FDA Approval Letter at 2);
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/XMJ56A003?jcsearch=21%20cfr%20314%20520&amp;summary=yes#jcite">21 C.F.R. &sect; 314.520</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Following FDA approval, additional clinical trials led to the development
of new protocols for administering the drugs, one of which called for "200
mg of mifepristone administered orally followed one to three days later by
0.8 mg of misoprostol administered vaginally" and could be "employed up to
sixty-three days' gestation." <i>Taft II</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X14RLFG003?jcsearch=444%20f%203d%20502&amp;summary=yes#jcite">444 F.3d at 505-06</a>. This new
protocol, called the Schaff protocol, changed (1) the dosage amounts of the
drugs, lowering the amount of mifepristone from 600 mg to 200 mg and
increasing the amount of misoprostol from .4 mg to .8 mg; (2) the number of
days between the drugs, from two days to between one and three; (3) the
method of administering the misoprostol, from orally at the clinic to
vaginally at home; and (4) the number of days' gestation up to which the
protocol could be successfully performed, from 49 to 63 days after the
woman's last menstrual period ("LMP"). The Schaff protocol was the primary
protocol implemented at Planned Parenthood's Ohio clinics following the
approval of mifepristone in 2000.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In 2006, Planned Parenthood's Ohio clinics shifted to a variation of the
Schaff protocol that called for self-administration of the misoprostol
buccally, i.e., via gum absorption. Because the first clinical trials for
buccal administration initially only went up to 56 days LMP, Planned
Parenthood limited this new protocol to that time period. By 2010,
additional trials had demonstrated the safety and efficacy of buccal
absorption up to 63 days LMP, and prior to the enforcement of the Act in
2011, Planned Parenthood began again offering patients the option of a
medical abortion up to 63 days LMP. <i>See, e.g.</i>, R. 134-3, Ex. 1 (S.E. Ohio
Medical Abortion Protocol at 385-86) (Page <cite>ID</cite> # 2131-32).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Once a drug has been approved, the FDA does not ban the sort of "off-label
<span CLASS="page_no" data-cite="696 f 3d 496" data-cite-type="PrimaryFederalReporter" data-cite-pageno="496" data-primary-citation="696 F.3d 490">[*496]</span> 
use" that Planned Parenthood uses in its clinics, i.e., prescribing the drug
for uses or in doses not identified in the approved labels.<a HREF="#fn400" name="fnref_fn400">[fn4]</a><i>Taft II</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X14RLFG003?jcsearch=444%20f%203d%20502&amp;summary=yes#jcite">444 F.3d at 505</a>. The State does not dispute that "[i]t is standard medical
practice in the United States for physicians to prescribe FDA-approved drugs
in dosages and for medical indications that were not specifically approved &mdash;
or even contemplated &mdash; by the FDA, particularly where the alternative use is
supported by adequate study." R. 133-1 (State's Resp. to Pls.' Facts at &para;
12) (Page <cite>ID</cite> # 1994).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  States, however, may limit off-label use. <i>Taft II</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=444%20f%203d%20502&amp;summary=yes#jcite">444 F.3d at 505</a>. And on
March 13, 2003, several members of the Ohio House of Representatives did
just that, introducing House Bill 126 to regulate the distribution of RU-486
and to criminalize a physician's failure to follow the regulations. The Act
was approved by both chambers and signed into law by the Governor on June
24, 2004, stating in relevant part:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      No person shall knowingly . . . prescribe RU-486 (mifepristone) to
    another for the purpose of inducing an abortion . . . unless <span CLASS="page_no" data-cite="2012 bl 254593 p 4" data-cite-type="Bloomberg" data-cite-pageno="4" data-primary-citation="">[**4]</span> the
    person . . . is a physician, the physician <i>satisfies all the</i>
    <i>criteria established by federal law</i> that a physician must satisfy in
    order to provide RU-486 (mifepristone) for inducing abortions, and
    the physician provides the RU-486 (mifepristone) to the other person
    for the purpose of inducing an abortion <i>in accordance with all</i>
    <i>provisions of federal law</i> that govern the use of RU-486
    (mifepristone) for inducing abortions.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
Ohio Rev.Code &sect; <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X4OGMFG5GVG0?jcsearch=Ohio%20Rev.%20Code%20%202919.123%20(A)&amp;summary=yes#jcite">2919.123</a>(A) (emphasis added). The Act also bans physicians
from "knowingly fail[ing] to comply with the applicable requirements of any
federal law that pertain to follow-up examinations or care for persons to
whom or for whom RU-486 (mifepristone) is provided for the purpose of
inducing an abortion," and requires physicians prescribing mifepristone to
submit reports under certain conditions. <i><cite>Id</cite>.</i> <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X4OGMFG5GVG0?jcsearch=Ohio%20Rev.%20Code%20%202919.123%20(B)&amp;summary=yes#jcite">&sect; 2919.123(B)</a>, (C). Physicians
who fail to comply with these terms will be "guilty of unlawful distribution
of an abortion-inducing drug, a felony of the fourth degree," and also
subject to administrative penalties, including revocation of professional
licenses. <i><cite>Id</cite>.</i> <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X4OGMFG5GVG0?jcsearch=Ohio%20Rev.%20Code%20%202919.123%20(E)&amp;summary=yes#jcite">&sect; 2919.123(E)</a>. The Act defines "federal law" as "any law,
rule, or regulation of the United States or any drug approval letter of the
food and drug administration of the United States that governs or regulates
the use of RU-486 (mifepristone) for the purpose of inducing abortions." <i></i><a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X4OGMFG5GVG0?jcsearch=Ohio%20Rev.%20Code%20%202919.123%20(F)(1)&amp;summary=yes#jcite">Id.
&sect; 2919.123(F)(1).</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Planned Parenthood submitted affidavits from clinic employees averring
that from the introduction of mifepristone in the United States until 2010,
regardless of which variation was in place, all of its patients chose one of
the alternative dosage regimens over the FDA protocol.<a HREF="#fn500" name="fnref_fn500">[fn5]</a> R. 134-3
(Brenner Decl. at &para; 5) (Page <cite>ID</cite> #2114); R. 134-4 (Clawson Decl. at &para; 5)
(Page <cite>ID</cite> #2150); R. 134-5 (Harrington Decl. at &para; 5) (Page <cite>ID</cite> # 2180); R.
134-6 (Lonn Decl. at &para; 5) (Page <cite>ID</cite> #2186).<a HREF="#fn600" name="fnref_fn600">[fn6]</a>
<span CLASS="page_no" data-cite="696 f 3d 497" data-cite-type="PrimaryFederalReporter" data-cite-pageno="497" data-primary-citation="696 F.3d 490">[*497]</span> 
Planned Parenthood's Ohio clinics offer medical abortions only through the
administration of mifepristone with misoprostol. Depending on the clinic,
Planned Parenthood reported that the percentage of women choosing medical
abortions up to 63 days LMP in 2009 was anywhere between fourteen and
fifty-five percent of its patients who were eligible. R. 134-3 (Brenner
Decl. at &para; 13) (Page <cite>ID</cite> #2115) (fourteen percent); R. 134-4 (Clawson Decl.
at &para; 16) (Page <cite>ID</cite> # 2152) (fifty-five percent); R. 134-5 (Harrington Decl.
at &para; 12) (Page <cite>ID</cite> # 2181) (twenty-two percent); R. 134-6 (Lonn Decl. at &para;
14) (Page <cite>ID</cite> #2187) (twenty-three percent). When the total numbers are
combined, Planned Parenthood performed a total of 6641 abortions up to 63
days LMP in 2009, of which 2067 were medical, or thirty-one percent.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Planned Parenthood offers evidence that the newer protocols have several
advantages over the FDA-approved protocol, both in terms of women's health
and access to abortions. The FDA plan does not permit the use of
mifepristone after 49 days LMP, but many women do not detect their pregnancy
until after 49 days LMP. R. 144-1 (Paul Decl. at &para; 57) (Page <cite>ID</cite> # 2393). The
FDA plan requires a higher dosage of mifepristone, which Planned Parenthood
asserts is not medically necessary (although it concedes the amount is
safe). <i></i><cite>Id. at &para; 58</cite>. <span CLASS="page_no" data-cite="2012 bl 254593 p 5" data-cite-type="Bloomberg" data-cite-pageno="5" data-primary-citation="">[**5]</span> Requiring the higher dosage of mifepristone (three pills
instead of one) also raises the overall cost to the patient by about $150
for the two extra mifepristone pills alone, which depending on the clinic in
question can amount to an increase in cost of twenty-eight to forty-two
percent. R. 134-3 (Brenner Decl. at &para; 9) (Page <cite>ID</cite> #2114) (medical abortions
cost $545); R. 134-4 (Clawson Decl. at &para; 12) (Page <cite>ID</cite> # 2151) (medical
abortions cost $410);<a HREF="#fn700" name="fnref_fn700">[fn7]</a> R. 134-5 (Harrington Decl. at &para; 8) (Page <cite>ID</cite>
#2180) (medical abortions cost $360); R. 134-6 (Lonn Decl. at &para; 9) (Page <cite>ID</cite>
#2186) (medical abortions cost $450). Because the FDA plan does not permit
the self-administration of the misoprostol, the FDA plan involves the extra
time, stress, and expense of a third doctor's office visit. The parties
dispute whether the medical community accepts that the alternative protocols
cause fewer side effects or have a higher success rate than the FDA-approved
regimes.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Planned Parenthood also points out several reasons why a woman may prefer
a medical abortion over a surgical abortion, aside from women with
particular health conditions that make one option medically preferable over
another. <i>See</i> R. 144-1 (Paul Decl. &para;&para; 49-55) (Page <cite>ID</cite> # 2390-92) <i>but see</i> R.
139-1 (Defs.' Mot. to Strike at 11) (Page <cite>ID</cite> # 2337) (objecting to testimony
on this subject because Paul is not a psychologist). We consider Paul's
testimony on this subject only to the extent that it reflects Paul's
personal experiences in providing abortions and the common sense observation
that "women know their own needs and desires and choose the abortion method
that is best for them." R. 144-1 (Paul Decl. &para; 50) (Page <cite>ID</cite> # 2390). The
State does not argue that such statements are factually false. Indeed, one
need not be a psychologist to observe that medical abortions involve
ingesting medication rather than the insertion of instruments into the
woman's body and that medical abortions terminate the pregnancy in the
privacy of a woman's home through a process of bleeding as opposed to in a
clinical setting. We need not conclude <i>why</i> women might prefer one procedure
over the
<span CLASS="page_no" data-cite="696 f 3d 498" data-cite-type="PrimaryFederalReporter" data-cite-pageno="498" data-primary-citation="696 F.3d 490">[*498]</span> 
other to acknowledge that the differences between the two procedures are
substantial and that such preferences may exist.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The State offers its own competing statistics regarding the frequency of
medical abortions in Ohio. Ohio requires mandatory reporting of induced
abortions, and the Ohio Department of Health reported that in 2008, 17.7% of
abortions in Ohio were medical/non-surgical and 80% were surgical. R. 128-16
(Paulson Decl. &para;&para; 6-7) (Page <cite>ID</cite> # 1930). The most common method of
medical/non-surgical abortion was a combination of mifepristone and
misoprostol.<a HREF="#fn800" name="fnref_fn800">[fn8]</a><i></i><cite>Id. at &para; 7</cite>. The State does not have data on how many
medical abortions follow the FDA-approved protocol or an alternative
protocol. In the public version of the Ohio Department of Health's
statistical report, Ohio observed that medical abortions were the "second
most common" method of abortion in Ohio and that "[FDA] approval [of
mifepristone] was expected to shift many of the early abortions from
surgical to non-surgical methods." <i>See</i> OHIO DEPARTMENT OF HEALTH, INDUCED
<span CLASS="page_no" data-cite="2012 bl 254593 p 6" data-cite-type="Bloomberg" data-cite-pageno="6" data-primary-citation="">[**6]</span> ABORTIONS IN OHIO (2008), <i>available online at</i>
http://www.odh.ohio.gov/healthstats/vitalstats/abortionmainpage.aspx.<a HREF="#fn900" name="fnref_fn900">[fn9]</a>
The State argues that medical abortions using the FDA-approved protocol are
safer than those that use off-label protocols. Since implementation, the FDA
received reports of eight deaths from serious infections following the use
of mifepristone to terminate a pregnancy, seven of whom used vaginal
administration of the misoprostol. R. 128-13 (2/24/2010 FDA Mifeprex Q &amp; A)
(Page <cite>ID</cite> # 1918).<a HREF="#fn1000" name="fnref_fn1000">[fn10]</a> The FDA could not state whether the use of
mifepristone was the cause of these deaths. <i><cite>Id</cite>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>B. Procedural History</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  After the Act was signed but before it took effect, Planned Parenthood
sued the Ohio Governor, the Ohio Attorney General, and a class of local
prosecutors in 2004 seeking to enjoin the enforcement of the Act. From the
beginning, Planned Parenthood has maintained that the Act is
unconstitutional for four independent reasons: (1) the Act is
unconstitutionally vague; (2) the Act violates a woman's right to bodily
integrity; (3) the Act imposes an undue burden on a woman's right to choose
an abortion; and (4) the Act fails adequately to protect a woman's health
and life. Appellant Br. at 3. To our knowledge, this is the first federal
challenge to state laws restricting the use of mifepristone to reach the
Court of Appeals. On September 22, 2004, the district court issued a
preliminary injunction enjoining enforcement of the entire Act on the
likelihood of the plaintiffs' success with
<span CLASS="page_no" data-cite="696 f 3d 499" data-cite-type="PrimaryFederalReporter" data-cite-pageno="499" data-primary-citation="696 F.3d 490">[*499]</span> 
respect to the lack of an exception for the health and life of a woman.
<i>Planned Parenthood Cincinnati Region v. Taft</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/XFQMNF?jcsearch=337%20f%20supp%202d%201040&amp;summary=yes#jcite">337 F.Supp.2d 1040</a> (S.D.Ohio
2004) ("<i>Taft</i> 7").<a HREF="#fn1100" name="fnref_fn1100">[fn11]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On appeal of the preliminary injunction, we held that the district court
erred in treating a health and life exception as a per se requirement for an
abortion regulation to be constitutional, but nonetheless affirmed the
issuance of a preliminary injunction on the necessity of a health exception
in this case. <i>Taft II</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X14RLFG003?jcsearch=444%20f%203d%20502&amp;summary=yes#jcite">444 F.3d 502</a>. In light of the Supreme Court's
then-recent decision in <i>Ayotte v. Planned Parenthood of Northern New</i>
<i>England</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X140GDU003?jcsearch=546%20us%20320&amp;summary=yes#jcite">546 U.S. 320</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=126%20supreme%20court%20961&amp;summary=yes#jcite">126 S.Ct. 961</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X140GDU003?jcsearch=163%20l%20ed%202d%20812&amp;summary=yes#jcite">163 L.Ed.2d 812</a> (2006), however, we
remanded for consideration of whether the injunction could be narrowed to
prohibit enforcement of only the unconstitutional portions or whether the
plaintiffs' other constitutional arguments warranted broad relief.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On remand, the district court granted' the plaintiffs' motion for summary
judgment on the first issue of vagueness and permanently enjoined the Act in
its entirety on this separate ground. <i>Planned Parenthood Cincinnati Region</i>
<i>v. Taft</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X16AM40003?jcsearch=459%20f%20supp%202d%20626&amp;summary=yes#jcite">459 F.Supp.2d 626</a> (S.D.Ohio 2006) ("<i>Taft III</i>"). The district court
held that the Act was ambiguous on whether compliance with the FDA-approved
protocol was required or whether off-label use was permissible. Defendants
appealed, and we sua sponte certified two questions of law to the Ohio
Supreme Court. The questions were: (1) "Does [the Act] mandate that
physicians in Ohio who perform abortions using mifepristone do so in
compliance with the forty-nine day gestational limit described in the FDA
approval letter?" and (2) "Does [the Act] mandate that physicians <span CLASS="page_no" data-cite="2012 bl 254593 p 7" data-cite-type="Bloomberg" data-cite-pageno="7" data-primary-citation="">[**7]</span> in Ohio
who perform abortions using mifepristone do so in compliance with the
treatment protocols and dosage indications described in the drug's final
printed labeling?" <i>Planned Parenthood Cincinnati Region v. Strickland</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X19556U003?jcsearch=531%20f%203d%20406&amp;summary=yes#jcite">531 F.3d 406</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X19556U003?jcsearch=531%20f%203d%20406&amp;summary=yes#jcite">412</a> (6th Cir.2008) ("<i>Strickland I</i>").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Ohio Supreme Court accepted the certified questions and answered both
in the affirmative. <i>Cordray v. Planned Parenthood Cincinnati Region</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=122%20ohio%20state%203d%20361&amp;summary=yes#jcite">122 Ohio St.3d 361</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X1B9S9S003?jcsearch=911%20north%20eastern%202d%20871&amp;summary=yes#jcite">911 N.E.2d 871</a> (2009). On August 6, 2009, we vacated the
permanent injunction and remanded the case to the district court to consider
<i>Cordray</i> in the first instance, leaving intact the previously affirmed
preliminary injunction "per our previous opinion." <i>Planned Parenthood Sw.</i>
<i>Ohio Region v. Strickland</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=331%20f%20appx%20387&amp;summary=yes#jcite">331 Fed.Appx. 387</a> (6th Cir.2009) ("<i>Strickland</i>
<i>II</i>") (unpublished order).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On remand, the parties cross-moved for summary judgment, the plaintiffs
again on their first claim of vagueness and the defendants on all four
claims.<a HREF="#fn1200" name="fnref_fn1200">[fn12]</a> The district court denied the plaintiffs' motion and granted
the defendants' motion with respect to the plaintiffs' vagueness challenge,
bodily integrity challenge, and undue burden on the right to choose
challenge. R. 161 (D. Ct. 5/23/11 Order). The district
<span CLASS="page_no" data-cite="696 f 3d 500" data-cite-type="PrimaryFederalReporter" data-cite-pageno="500" data-primary-citation="696 F.3d 490">[*500]</span> 
court held that there remained genuine issues of material fact regarding the
plaintiffs' undue burden claim with respect to a woman's health exception.
<i></i><cite>Id. at 26-27</cite>. At Planned Parenthood's request, the district court entered
final judgment under Federal Rule of Civil Procedure <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X144L48003?jcsearch=Federal%20Rule%20of%20Civil%20Procedure%2054(b)&amp;summary=yes#jcite">54</a>(b) on the three
claims for which summary judgment for the defendants was granted and stayed
the remaining proceedings pending appeal. <i>Planned Parenthood Southwest Ohio</i>
<i>Region v. DeWine</i>, <cite>No. 1:04-CV-493</cite>, [<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X1GCK60003?jcsearch=2011%20BL%20234382&amp;summary=yes#jcite">2011 BL 234382</a>], 2011 WL 4063999, at *3 (S.D.Ohio Sept.
13, 2011) ("<i>DeWine</i>"). This appeal followed.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>II. JURISDICTION</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court had federal subject matter jurisdiction over Planned
Parenthood's constitutional claims under <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/XEIMUO003?jcsearch=28%20usc%201331&amp;summary=yes#jcite">28 U.S.C. &sect; 1331</a>. Our jurisdiction,
however, is less straightforward. We have jurisdiction under
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/XEIMU8003?jcsearch=28%20usc%201291&amp;summary=yes#jcite">28 U.S.C. &sect; 1291</a> to review final orders of the district court. Typically,
when a district court grants summary judgment on some but not all claims,
the decision is not a final order for appellate purposes. However, under
Federal Rule of Civil Procedure <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X144L48003?jcsearch=Federal%20Rule%20of%20Civil%20Procedure%2054(b)&amp;summary=yes#jcite">54</a>(b), the district court may certify a
partial grant of summary judgment for immediate appeal "if the court
expressly determines that there is no just reason for delay." Fed.R.Civ.P.
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X144L48003?jcsearch=Federal%20Rule%20of%20Civil%20Procedure%2054(b)&amp;summary=yes#jcite">54</a>(b). If Rule 54(b) certification is improper, we lack jurisdiction because
there would be no final order from which the parties could take an appeal.
<i>Lowery v. Fed. Express Corp.</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X13DBPU003?jcsearch=426%20f%203d%20817&amp;summary=yes#jcite">426 F.3d 817</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X13DBPU003?jcsearch=426%20f%203d%20817&amp;summary=yes#jcite">820</a> (6th Cir.2005); <i>see also</i>
<i>Justice v. Pendleton Place Apartments</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X398DD?jcsearch=40%20f%203d%20139&amp;summary=yes#jcite">40 F.3d 139</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X398DD?jcsearch=40%20f%203d%20139&amp;summary=yes#jcite">141</a> (6th Cir.1994).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Proper certification under <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X144L48003?jcsearch=FED.R.CIV.P%2054(b)&amp;summary=yes#jcite">Rule 54(b)</a> is a two-step process. "First, the
district court must expressly direct the entry of final judgment as to one
or more but fewer than all the claims or parties in a case. Second, the
district court must expressly determine that there is no just reason to
delay appellate review." <i>Gen. Acquisition, Inc. v. GenCorp, Inc.</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X54D07?jcsearch=23%20f%203d%201022&amp;summary=yes#jcite">23 F.3d 1022</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X54D07?jcsearch=23%20f%203d%201022&amp;summary=yes#jcite">1026</a> (6th Cir.1994) (internal quotation marks and alterations
omitted). We apply de novo review to the district court's conclusions on the
first inquiry and review <span CLASS="page_no" data-cite="2012 bl 254593 p 8" data-cite-type="Bloomberg" data-cite-pageno="8" data-primary-citation="">[**8]</span> for abuse of discretion the district court's
determination of no just reason for delay. <i></i><a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X54D07?jcsearch=23%20F.3d%201022&amp;summary=yes#jcite">Id. at 1027</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The first inquiry &mdash; whether the district court entered judgment as to one
or more but fewer than all of Planned Parenthood's claims &mdash; is a difficult
question. The parties were asked to submit additional letter briefs on this
issue, and on de novo review, we agree with them that the remaining claims
are in fact separate from the one claim remaining below.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Courts apply many different tests to determine whether multiple claims
exist for the purposes of <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X144L48003?jcsearch=FED.R.CIV.P%2054(b)&amp;summary=yes#jcite">Rule 54(b)</a>, and we have previously recognized that
there is no "`generally accepted test'" for determining what constitutes a
separate claim. <i>Gen. Acquisition</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X54D07?jcsearch=23%20f%203d%201022&amp;summary=yes#jcite">23 F.3d at 1028</a> (quoting 10 CHARLES ALAN
WRIGHT, ARTHUR *R. MILLER &amp; MARY KAY KANE, FEDERAL PRACTICE AND PROCEDURE <cite>&sect;
2657</cite> (3d ed.1998)); <i>see also Liberty Mut. Ins. Co. v. Wetzel</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X5C93C?jcsearch=424%20us%20737&amp;summary=yes#jcite">424 U.S. 737</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X5C93C?jcsearch=424%20us%20737&amp;summary=yes#jcite">743</a> n. 4, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=96%20supreme%20court%201202&amp;summary=yes#jcite">96 S.Ct. 1202</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X5C93C?jcsearch=47%20l%20ed%202d%20435&amp;summary=yes#jcite">47 L.Ed.2d 435</a> (1976) (declining to adopt a
definitive test). Our circuit has traditionally applied the "operative,
facts" test, which defines "[a] `claim' under Rule 54(b) `[as] the aggregate
of operative facts which give rise to a right enforceable in the courts'
even if the party has raised different theories of relief." <i>GenCorp, Inc. v.</i>
<i>Olin Corp.</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/XG6PAT?jcsearch=390%20f%203d%20433&amp;summary=yes#jcite">390 F.3d 433</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/XG6PAT?jcsearch=390%20f%203d%20433&amp;summary=yes#jcite">442</a> (6th Cir.2004) (quoting <i>Gen. Acquisition</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X54D07?jcsearch=23%20f%203d%201022&amp;summary=yes#jcite">23 F.3d at 1028</a>), <i>cert. denied</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X13BN74003?jcsearch=546%20us%20935&amp;summary=yes#jcite">546 U.S. 935</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=126%20supreme%20court%20420&amp;summary=yes#jcite">126 S.Ct. 420</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=163%20l%20ed%202d%20320&amp;summary=yes#jcite">163 L.Ed.2d 320</a>
(2005); <i>McIntyre v. First Nat'l Bank of Cincinnati</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X49P1J?jcsearch=585%20f%202d%20190&amp;summary=yes#jcite">585 F.2d 190</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X49P1J?jcsearch=585%20f%202d%20190&amp;summary=yes#jcite">191</a> (6th
Cir.1978). We have held, for example, that a party brings only
<span CLASS="page_no" data-cite="696 f 3d 501" data-cite-type="PrimaryFederalReporter" data-cite-pageno="501" data-primary-citation="696 F.3d 490">[*501]</span> 
one "claim" under <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X144L48003?jcsearch=FED.R.CIV.P%2054(b)&amp;summary=yes#jcite">Rule 54(b)</a> when he raises both a Title VII retaliation
claim and a state-law breach-of-contract claim, where the basis for the
alleged breach and the Title VII claim was the same retaliatory act by the
employer. <i>Lowery</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X13DBPU003?jcsearch=426%20f%203d%20817&amp;summary=yes#jcite">426 F.3d at 821</a>. We reached a similar result in <i>General</i>
<i>Acquisition</i>, where the "claims" &mdash; breach of fiduciary duty, fraud, and
negligence &mdash; all required proof of the same facts leading up to the same
hostile takeover and were functionally separate theories for recovering for
the same injury. <i>Gen. Acquisition</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X54D07?jcsearch=23%20f%203d%201022&amp;summary=yes#jcite">23 F.3d at 1029</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We are mindful not to apply the "operative facts" test too broadly,
however. In <i>Sears, Roebuck &amp; Co. v. Mackey</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X5C3BV?jcsearch=351%20us%20427&amp;summary=yes#jcite">351 U.S. 427</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X5C3BV?jcsearch=76%20supreme%20court%20895&amp;summary=yes#jcite">76 S.Ct. 895</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=100%20l%20ed%201297&amp;summary=yes#jcite">100 L.Ed. 1297</a> (1956), the Supreme Court sustained appellate jurisdiction
over a dismissed Sherman Act claim even though it "rest[ed] in part on some
of the facts that [we]re involved in" pending state-law claims, including a
claim for unlawful destruction of one of the same businesses that served the
basis of the Sherman Act claim. <i>Id.</i> at 437 n. 9, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X5C3BV?jcsearch=76%20supreme%20court%20895&amp;summary=yes#jcite">76 S.Ct. 895</a>. We applied
this same principle in <i>GenCorp</i>, where we concluded that the aggregate set of
operative facts to support a claim of CERCLA contribution liability was
wholly distinct from the facts necessary to support the claim of breach of
insurance contract, despite the relationship of both claims to the same
improper toxic waste disposal. <i>GenCorp</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/XG6PAT?jcsearch=390%20f%203d%20433&amp;summary=yes#jcite">390 F.3d at 442</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We have not addressed the application of <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X144L48003?jcsearch=FED.R.CIV.P%2054(b)&amp;summary=yes#jcite">Rule 54(b)</a> to multiple
constitutional claims against the same statute before. Other circuits have,
although sometimes applying different tests. <i>See, e.g., Jordan v. Pugh</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X135CJS003?jcsearch=425%20f%203d%20820&amp;summary=yes#jcite">425 F.3d 820</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X135CJS003?jcsearch=425%20f%203d%20820&amp;summary=yes#jcite">827</a> (10th Cir.2005) (holding facial vagueness and <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=USCONST%20AMEND%20I&amp;summary=yes#jcite">First
Amendment</a> overbreadth challenge to same statute were one claim); <i>Samaad v.</i>
<i>City of Dallas</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/XN8A3JQNB5G0?jcsearch=940%20f%202d%20925&amp;summary=yes#jcite">940 F.2d 925</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/XN8A3JQNB5G0?jcsearch=940%20f%202d%20925&amp;summary=yes#jcite">930-32</a> (5th Cir.1991) (holding
equal-protection and takings-clause challenges were separate claims),
<span CLASS="page_no" data-cite="2012 bl 254593 p 9" data-cite-type="Bloomberg" data-cite-pageno="9" data-primary-citation="">[**9]</span> <i>abrogated on other grounds as recognized by Rosedale Missionary Baptist</i>
<i>Church v. New Orleans City</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X1F7OCS003?jcsearch=641%20f%203d%2086&amp;summary=yes#jcite">641 F.3d 86</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X1F7OCS003?jcsearch=641%20f%203d%2086&amp;summary=yes#jcite">88-89</a> (5th Cir.2011). In <i>Jordan</i>,
for example, the Tenth Circuit relied heavily on the traditional overlap
between facial vagueness and overbreadth challenges. The court treated the
arguments as part of the same claim because both "involve[d] the same
nucleus of facts, . . . require[d] similar analysis of the terms and reach
of the challenged provision[,]" and if raised on separate appeals, would
require the court "to go over the same ground that it had covered in the
first appeal." <i>Jordan</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X135CJS003?jcsearch=425%20f%203d%20820&amp;summary=yes#jcite">425 F.3d at 827-28</a> (internal quotation marks
omitted).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We view these cases as informative and largely consistent with our
approach today, but we decline to adopt a new test for analyzing multiple
facial challenges to the same statute. Statutory challenges will certainly
all contain at least one common operative fact &mdash; the passage of the
challenged law. But the <i>aggregate</i> of operative facts will not necessarily
include just the challenged law's existence; rather, we must also consider
the facts relating to the law's impact on similar or distinct constitutional
rights. A single law that causes distinct injuries to distinct
constitutional rights is not so easily analogized to a single retaliatory
employment action causing one injury that can be vindicated through multiple
channels of relief.<a HREF="#fn1300" name="fnref_fn1300">[fn13]</a><i>See Lowery</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X13DBPU003?jcsearch=426%20f%203d%20817&amp;summary=yes#jcite">426 F.3d at 821</a> (considering
<span CLASS="page_no" data-cite="696 f 3d 502" data-cite-type="PrimaryFederalReporter" data-cite-pageno="502" data-primary-citation="696 F.3d 490">[*502]</span> 
plaintiffs theories as all "seek[ing] to recover for the same underlying
injury.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  With that in mind, we turn to the claims in this case. Here, there are
four potential claims that all seek to disqualify the Act as
unconstitutional and admittedly seek the same declaratory and injunctive
relief. However, the aggregate of operative facts that give rise to each of
the rights to be vindicated are sufficiently separate to confer jurisdiction
despite the presence of some overlap. Count 1 alleges that the Act is
unconstitutionally vague. The right at issue is the right of physicians to
have notice of what behavior is criminal before they can be prosecuted.
Because this is a legal question, the relevant inquiry is whether a
reasonable physician would know that certain acts when performing an
abortion are criminal or not. Count 2 alleges that the Act violates the
right to bodily integrity of the women obtaining abortions. The facts
necessary to establish this violation include proving that the Act will
result in forcible physical intrusions by the state into a woman's body
against their will and whether the state has a compelling need for such an
invasion. Count 2 bears no relation to whether the Act gives physicians
constitutional notice of criminal conduct.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Counts 3 and 4 are the most similar in that they both allege violations of
the right not to have an undue burden imposed on the abortion decision. But
although we apply the same legal framework to analyze both claims, the
injuries (and the constitutional rights to be vindicated) are distinct from
each other and from Counts 1 and 2. Count 3, the health and life argument,
considers whether the Act imposes <span CLASS="page_no" data-cite="2012 bl 254593 p 10" data-cite-type="Bloomberg" data-cite-pageno="10" data-primary-citation="">[**10]</span> an undue burden on certain women with
medical conditions that make a medical abortion safer than a surgical
abortion, or an alternative protocol safer than the FDA protocol. Count 4,
asserting a challenge based on the burden on the right to choose, considers
whether the added costs and inconveniences of the FDA-protocol, or the lack
of a medical option entirely in certain contexts, will prevent a large
fraction of women from exercising their constitutional right to choose
abortion. The alleged injuries affect entirely separate classes of women:
those whose lives may be placed at risk by the Act (Count 3) and those whose
decision to choose abortion will be unduly burdened by the extra hurdles
imposed by the Act (Count 4). Whether the women with health issues are
burdened by the Act bears no relation to whether the women with access
issues will be burdened; proof of a constitutional violation against the
rights of the former will depend on entirely separate facts from those
necessary to prove a violation against the latter.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  After reviewing the operative facts necessary to give rise to relief in
each claim, we hold that their differences sufficiently outweigh what they
have in common. Because each count involves distinct facts relating to
separate injuries, each count is a separate claim for purposes of Rule
54(b).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The second inquiry is also satisfied here. The district court
independently reviewed the request for Rule 54(b) certification and issued
an order expressly determining that there was no just reason for delay and
expressly directing the entry of final judgment as to one or more but fewer
than all claims in this case. <i>DeWine</i>, 2011 WL 4063999, at *3; <i>see GenCorp</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=390%20f%203d%20433&amp;summary=yes#jcite">390 F.3d at 442</a>. The
<span CLASS="page_no" data-cite="696 f 3d 503" data-cite-type="PrimaryFederalReporter" data-cite-pageno="503" data-primary-citation="696 F.3d 490">[*503]</span> 
district court explicitly weighed the non-exhaustive list of factors we have
provided for determining whether to find just reason for delay. Those
factors include:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      (1) the relationship between the adjudicated and the unadjudicated
    claims; (2) the possibility that the need for review might or might
    not be mooted by future developments in the district court; (3) the
    possibility that the reviewing court might be obliged to consider
    the same issue a second time; (4) the presence or absence of a claim
    or counterclaim which could result in set-off against the judgment
    sought to be made final; (5) miscellaneous factors such as delay,
    economic and solvency considerations, shortening the time of trial,
    frivolity of competing claims, expense, and the like.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i>Corrosioneering, Inc. v. Thyssen Envtl. Sys., Inc.</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=807%20f%202d%201279&amp;summary=yes#jcite">807 F.2d 1279</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=807%20f%202d%201279&amp;summary=yes#jcite">1283</a> (6th
Cir.1986).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court considered the separateness of the claims, the
unlikelihood that the need for appellate review would be mooted by future
developments, the unlikelihood of duplicate review of related issues, the
lack of off-setting claims, and the possibility that immediate appeal would
shorten the time and expense of trial. The district court's balancing of
these issues was riot an abuse of discretion. Therefore, we agree that
certification under Rule 54(b) was proper in this case, and we have
jurisdiction to entertain the appeal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>III. STANDARD <span CLASS="page_no" data-cite="2012 bl 254593 p 11" data-cite-type="Bloomberg" data-cite-pageno="11" data-primary-citation="">[**11]</span> OF REVIEW</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We review de novo a district court's grant of summary judgment. <i>Int'l</i>
<i>Union v. Cummins, Inc.</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=434%20f%203d%20478&amp;summary=yes#jcite">434 F.3d 478</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=434%20f%203d%20478&amp;summary=yes#jcite">483</a> (6th Cir.2006). In doing so, we
review the evidence and draw all inferences in the light most favorable to
Planned Parenthood as the nonmoving party. <i>Id.</i> "Credibility determinations,
the weighing of the evidence, and the drawing of legitimate inferences from
the facts are jury functions, not those of a judge." <i>Anderson v. Liberty</i>
<i>Lobby, Inc.</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=477%20us%20242&amp;summary=yes#jcite">477 U.S. 242</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=477%20us%20242&amp;summary=yes#jcite">255</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=106%20supreme%20court%202505&amp;summary=yes#jcite">106 S.Ct. 2505</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=91%20l%20ed%202d%20202&amp;summary=yes#jcite">91 L.Ed.2d 202</a> (1986).
Summary judgment is appropriate only if "the movant shows that there is no
genuine dispute as to any material fact and the movant is entitled to
judgment as a matter of law." Fed.R.Civ.P. <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=FRCIVPRO%2056&amp;summary=yes#jcite">56</a>(a).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>IV. VAGUENESS CLAIM</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Planned Parenthood's first challenge is well-suited for summary judgment
because it involves only a question of statutory interpretation. An Act
criminalizing certain abortion procedures will not be unconstitutionally
vague if it "provides doctors of ordinary intelligence a reasonable
opportunity to know what is prohibited[,] . . . sets forth relatively clear
guidelines as to prohibited conduct[,] and provides objective criteria to
evaluate whether a doctor has performed a prohibited procedure." <i>Gonzales v.</i>
<i>Carkart</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=550%20us%20124&amp;summary=yes#jcite">550 U.S. 124</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=550%20us%20124&amp;summary=yes#jcite">149</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=127%20supreme%20court%201610&amp;summary=yes#jcite">127 S.Ct. 1610</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=167%20l%20ed%202d%20480&amp;summary=yes#jcite">167 L.Ed.2d 480</a> (2007) (internal
quotation marks omitted). Given the constraints of the English language, a
law need not contain "meticulous specificity" to avoid constitutional
infirmity. <i>Grayned v. City of Rockford</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=408%20us%20104&amp;summary=yes#jcite">408 U.S. 104</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=408%20us%20104&amp;summary=yes#jcite">110</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=92%20supreme%20court%202294&amp;summary=yes#jcite">92 S.Ct. 2294</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=33%20l%20ed%202d%20222&amp;summary=yes#jcite">33 L.Ed.2d 222</a> (1972). It must reasonably "define[] the line between
potentially criminal conduct on the one hand and lawful abortion on the
other," <i>Gonzales</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=550%20us%20124&amp;summary=yes#jcite">550 U.S. at 149</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=127%20supreme%20court%201610&amp;summary=yes#jcite">127 S.Ct. 1610</a>. The statute also must be
read "precisely as the highest court of the State has interpreted it."
<i>Wainwright v. Stone</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=414%20us%2021&amp;summary=yes#jcite">414 U.S. 21</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=414%20us%2021&amp;summary=yes#jcite">22-23</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=94%20supreme%20court%20190&amp;summary=yes#jcite">94 S.Ct. 190</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=38%20l%20ed%202d%20179&amp;summary=yes#jcite">38 L.Ed.2d 179</a> (1973)
(internal quotation marks omitted). A state's highest court is "the final
arbiter of what is state law." <i>West v. Am. Tel. &amp; Tel Co.</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=311%20us%20223&amp;summary=yes#jcite">311 U.S. 223</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=311%20us%20223&amp;summary=yes#jcite">236</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=61%20supreme%20court%20179&amp;summary=yes#jcite">61 S.Ct. 179</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=85%20l%20ed%20139&amp;summary=yes#jcite">85 L.Ed. 139</a> (1940).
</p></div>
<span CLASS="page_no" data-cite="696 f 3d 504" data-cite-type="PrimaryFederalReporter" data-cite-pageno="504" data-primary-citation="696 F.3d 490">[*504]</span> <div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court initially held that the Act was unconstitutionally
vague because the term "federal law" was not defined with sufficient
certainty to provide notice of what the Act prohibited. <i>Toft III</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=459%20f%20supp%202d%20626&amp;summary=yes#jcite">459 F.Supp.2d at 637</a>. We agreed that each party had presented "contrary, yet
plausible, interpretations," of the language in the Act requiring that
doctors prescribing mifepristone "comply with `federal law.'" <i>Strickland I</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=531%20f%203d%20406&amp;summary=yes#jcite">531 F.3d at 407</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=531%20f%203d%20406&amp;summary=yes#jcite">411</a>. The State viewed the language as requiring compliance
with the FDA-approved protocol and gestational limits in the final printed
labeling; Planned Parenthood viewed the language as requiring compliance
only with the eight Subpart H restrictions addressing physician
qualifications to prescribe the drug. <i>Id.</i> at 411. We therefore asked the
Ohio Supreme Court to clarify, and the Ohio Supreme Court held that under
the Act, "a physician may provide mifepristone for the purpose of inducing
an abortion only through the patient's 49th day of pregnancy and only by
using the dosage indications and treatment protocols expressly approved by
the FDA in the drug's final printed labeling as incorporated by the drug
approval letter." <i>Cordray</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=911%20north%20eastern%202d%20871&amp;summary=yes#jcite">911 N.E.2d at 879</a>.<a HREF="#fn1400" name="fnref_fn1400">[fn14]</a> In light of this
clarification, the district court held that the Act was no longer
unconstitutionally vague because a reasonable person would know what conduct
<span CLASS="page_no" data-cite="2012 bl 254593 p 12" data-cite-type="Bloomberg" data-cite-pageno="12" data-primary-citation="">[**12]</span> was prohibited. R. 161 (D. Ct. 5/23/11 Order at 18).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The simple fact that the Ohio Supreme Court adopted the State's
interpretation of the Act does not mean that the Act is not
unconstitutionally vague. However, we agree with the State that the Ohio
Supreme Court's explicit interpretation of the Act in <i>Cordray</i> resolved any
facial vagueness concerns we might have had. Planned Parenthood points to
four primary areas that it argues the <i>Cordray</i> opinion leaves unresolved. The
district court rejected all of these issues as either unsupported by <i>Cordray</i>
or cured by scienter, and we agree. <i>See</i> R. 161 (D. Ct. 5/23/11 Order at
13-21).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  First, Planned Parenthood argues that because <i>Cordray</i> reached its holding
by incorporating parts of the final printed labeling ("FPL") into the
approval letter, all ninety plus documents submitted in support of the
approval letter must similarly be incorporated, including documents with
unclear meaning. This same dilemma was presented to the Ohio Supreme Court
in <i>Cordray</i>, however, and rejected. The Ohio Supreme Court explicitly
discussed what requirements the FDA-approval letter incorporated from the
FPL and why: "the FDA based its approval of mifepristone on its use as
recommended in the labeling text, thereby incorporating "that text into its
letter of approval." <i>Cordray</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=911%20north%20eastern%202d%20871&amp;summary=yes#jcite">911 N.E.2d at 878</a>. The recommended use in the
FPL consisted of the "gestational limit, dosage indications, or treatment
protocols" approved by the FDA. <i>Id.</i> at 877. Lest there be any ambiguity in
that, the Ohio Supreme Court specifically stated that "[a]dministering
mifepristone to induce an abortion beyond the 49th day of pregnancy," or
"[u]sing any other dosage indication or treatment protocol" other
<span CLASS="page_no" data-cite="696 f 3d 505" data-cite-type="PrimaryFederalReporter" data-cite-pageno="505" data-primary-citation="696 F.3d 490">[*505]</span> 
than the FDA-approved protocol, "would not be in accordance with the drug
approval letter" and would be a violation of the Act. <i>Id.</i> at 878.<a HREF="#fn1500" name="fnref_fn1500">[fn15]</a>
Planned Parenthood's ability to point to other documents on which the FDA
may have also "based its approval of mifepristone" lifts one phrase from the
<i>Cordray</i> opinion out of its otherwise unmistakable context. A reasonable
physician would not think that he had to scour the other ninety documents
cited in the approval letter, which mostly consisted of studies and evidence
in support of approving the drug, to determine whether his planned use of
mifepristone would be legal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Second, Planned Parenthood argues that even if only the FPL is
incorporated, the Act is still vague because the FPL itself consisted of
four documents, which contain internal contradictions that might confuse
physicians. For example, Planned Parenthood notes that the Medication Guide
recognizes that physicians prescribe drugs "off-label." But no reasonable
physician would view this reference as permitting off-label prescription of
mifepristone when <i>Cordray</i> makes clear that physicians must stick to the FDA
protocol. When a state's highest court interprets a statute, its
construction is considered part of the statute itself. <i>Wain-might</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=414%20us%2021&amp;summary=yes#jcite">414 U.S. at 22-23</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=94%20supreme%20court%20190&amp;summary=yes#jcite">94 S.Ct. 190</a>. Mathematical certainty is not required.
<i>Grayned</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=408%20us%20104&amp;summary=yes#jcite">408 U.S. at 110</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=92%20supreme%20court%202294&amp;summary=yes#jcite">92 S.Ct. 2294</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Third, Planned Parenthood argues that the FPL is subject to <span CLASS="page_no" data-cite="2012 bl 254593 p 13" data-cite-type="Bloomberg" data-cite-pageno="13" data-primary-citation="">[**13]</span> frequent
revision, with no clear-instruction to physicians on what would happen in
the event of a revision. Appellant Br. at 32. However, the risk of possible
revision is not enough to make the Act unconstitutionally vague on its face
when the Act is otherwise clear. This argument was also presented and
addressed by the Ohio Supreme Court. <i>Cordray</i> noted that despite two
subsequent revisions, none had altered the gestational limits, dosage
indications, or treatment protocols "originally approved by the FDA."
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=911%20north%20eastern%202d%20871&amp;summary=yes#jcite">911 N.E.2d at 875</a>. If and when the FDA makes revisions to the approved
regimen in the FPL that render <i>Cordray</i>'s interpretation of the Act vague, a
future challenge will be better suited to reviewing such changes rather than
our engaging in speculative guesses today.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Fourth, Planned Parenthood points to other supposedly vague terms still
present in the Act, such as "criteria" or "provisions," claiming that these
terms make it impossible to ascertain what is prohibited. Appellant Br. at
36. But <i>Cordray</i> made clear what a physician must to do comply with the Act.
Any risk of uncertainty regarding hidden, extra requirements is cured by the
scienter provisions, which forbid penalty under the Act unless a doctor
knowingly violates one of the requirements. A physician with a good-faith
belief that a certain action would comply with the Act or a physician who
accidentally takes an action not in compliance with the Act would not be
penalized. <i>Gonzales</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=550%20us%20124&amp;summary=yes#jcite">550 U.S. at 149-50</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=127%20supreme%20court%201610&amp;summary=yes#jcite">127 S.Ct. 1610</a>. The same exception
would apply to physicians who intend that their patients return for the
requisite follow-up visit, but whose patients decide on their own not to
come. <i>See id.</i> at 155, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=127%20supreme%20court%201610&amp;summary=yes#jcite">127 S.Ct. 1610</a>. Planned Parenthood's remaining
vagueness arguments relating to specific hypothetical scenarios that are
best left to future, as-applied
<span CLASS="page_no" data-cite="696 f 3d 506" data-cite-type="PrimaryFederalReporter" data-cite-pageno="506" data-primary-citation="696 F.3d 490">[*506]</span> 
challenges should an individual be prosecuted under an obscure reference in
one of those documents. As interpreted by the Ohio Supreme Court, the Act is
not vague.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>V. BODILY-INTEGRITY CLAIM</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Under the substantive due process clause of the Fourteenth Amendment,
individuals possess a constitutional right to be free from forcible physical
intrusions of their bodies against their will, absent a compelling state
interest. <i>See Winston v. Lee</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=470%20us%20753&amp;summary=yes#jcite">470 U.S. 753</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=470%20us%20753&amp;summary=yes#jcite">766</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=105%20supreme%20court%201611&amp;summary=yes#jcite">105 S.Ct. 1611</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=84%20l%20ed%202d%20662&amp;summary=yes#jcite">84 L.Ed.2d 662</a> (1985) (state cannot surgically remove potential evidence
from a suspect's body without consent given the severity of the intrusion
and lack of compelling state interest); <i>Schmerber v. California</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=384%20us%20757&amp;summary=yes#jcite">384 U.S. 757</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=384%20us%20757&amp;summary=yes#jcite">771-72</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=86%20supreme%20court%201826&amp;summary=yes#jcite">86 S.Ct. 1826</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=16%20l%20ed%202d%20908&amp;summary=yes#jcite">16 L.Ed.2d 908</a> (1966) (forcible
blood-alcohol test constitutional because specific individual's risk of
trauma or injury low and state's interest in evidence high). Planned
Parenthood argues that the Act in this case is akin to a forcible physical
intrusion because women who desire a medical abortion between 50 and 63 days
LMP are "forced" to undergo surgery due to the unavailability of
mifepristone during those days. <i>See</i> Appellant Br. at 44 (arguing that
surgical abortions are "forced," despite being performed with patient
consent, because the woman would have had a medical abortion but for its
unavailability).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Fourteenth Amendment undoubtedly protects <span CLASS="page_no" data-cite="2012 bl 254593 p 14" data-cite-type="Bloomberg" data-cite-pageno="14" data-primary-citation="">[**14]</span> as a liberty interest the
right against forcible physical intrusions of the body by the government.
<i>Rochin v. California</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=342%20us%20165&amp;summary=yes#jcite">342 U.S. 165</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=342%20us%20165&amp;summary=yes#jcite">172-73</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=72%20supreme%20court%20205&amp;summary=yes#jcite">72 S.Ct. 205</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=96%20l%20ed%20183&amp;summary=yes#jcite">96 L.Ed. 183</a>
(1952) (state cannot forcibly pump detainee's stomach to obtain evidence).
Although the Supreme Court has declined formally to label its review in this
context as "strict scrutiny," <i>see Riggins v. Nevada</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=504%20us%20127&amp;summary=yes#jcite">504 U.S. 127</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=504%20us%20127&amp;summary=yes#jcite">136</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=118%20l%20ed%202d%20479&amp;summary=yes#jcite">118 L.Ed.2d 479</a> (1992), the cases still ask whether the
government has adequately demonstrated a compelling need for the intrusion,
a lack of reasonable alternatives, as well as procedural and medical
safeguards, <i>see id.</i> at 135-36, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=112%20supreme%20court%201810&amp;summary=yes#jcite">112 S.Ct. 1810</a>.<a HREF="#fn1600" name="fnref_fn1600">[fn16]</a><i>See also Washington v.</i>
<i>Harper</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=494%20us%20210&amp;summary=yes#jcite">494 U.S. 210</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=494%20us%20210&amp;summary=yes#jcite">229</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=110%20supreme%20court%201028&amp;summary=yes#jcite">110 S.Ct. 1028</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=108%20l%20ed%202d%20178&amp;summary=yes#jcite">108 L.Ed.2d 178</a> (1990) ("The
forcible injection of medication into a non-consenting person's body
represents a substantial interference with that person's liberty" requiring
an important and legitimate state interest); <i>Cruzan v. Dir., Mo. Dep't of</i>
<i>Health</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=497%20us%20261&amp;summary=yes#jcite">497 U.S. 261</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=497%20us%20261&amp;summary=yes#jcite">269</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=497%20us%20261&amp;summary=yes#jcite">281</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=110%20supreme%20court%202841&amp;summary=yes#jcite">110 S.Ct. 2841</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=111%20l%20ed%202d%20224&amp;summary=yes#jcite">111 L.Ed.2d 224</a> (1990)
("This notion of bodily integrity has been embodied in the requirement that
informed consent is generally required for medical treatment," but state
also has interest in life and informed consent).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Although we understand why Planned Parenthood took this approach &mdash;
requiring the government to show a compelling state interest for the Act
would relieve Planned Parenthood of its obligation to show an undue burden
on the right to choose an abortion &mdash; this argument is unconvincing. "Strict
scrutiny, of course, no longer applies to abortion legislation." <i>Women's</i>
<i>Med. Prof I Corp. v. Taft</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=353%20f%203d%20436&amp;summary=yes#jcite">353 F.3d 436</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=353%20f%203d%20436&amp;summary=yes#jcite">444</a> (6th Cir.2003). The Supreme
Court has made clear that abortion regulations, even those limiting access
to a certain kind of procedure, are analyzed under the undue-burden
framework and not the classic physical-intrusion framework discussed above.
We could just as easily say that
<span CLASS="page_no" data-cite="696 f 3d 507" data-cite-type="PrimaryFederalReporter" data-cite-pageno="507" data-primary-citation="696 F.3d 490">[*507]</span> 
the partial-birth abortion ban "forces" a woman to have a D &amp; E abortion
when she may prefer (the banned) D &amp; X abortion, but that does not negate
the consent the woman must give in order for her physician to perform the
procedure. If the only available abortion method is so undesirable as to
make the woman choose to have no abortion at all, the undue-burden framework
remains the appropriate remedy for addressing that concern.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We emphasize, however, that policies restricting a method of abortion do
impact a woman's right to bodily integrity. "As far back as 1891, the
Supreme Court recognized that no right is held more sacred, or is more
carefully guarded[,] than the right of every individual to the possession
and control of his own person, free from all restraint or interference of
others, unless by clear and unquestionable authority of law." <i>Kallstrom v.</i>
<i>City of Columbus</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=136%20f%203d%201055&amp;summary=yes#jcite">136 F.3d 1055</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=136%20f%203d%201055&amp;summary=yes#jcite">1062</a> (6th Cir.1998) (internal quotation
marks and alterations omitted); <i>see also Soper v. Hoben</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=195%20f%203d%20845&amp;summary=yes#jcite">195 F.3d 845</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=195%20f%203d%20845&amp;summary=yes#jcite">852</a>
(6th Cir.1999), <i>cert. denied</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=530%20us%201262&amp;summary=yes#jcite">530 U.S. 1262</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=120%20supreme%20court%202719&amp;summary=yes#jcite">120 S.Ct. 2719</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=147%20l%20ed%202d%20984&amp;summary=yes#jcite">147 L.Ed.2d 984</a>
(2000). Government restrictions on abortions are a form of interference with
the right to bodily integrity and control over an individual's person.
<i>Planned Parenthood of Se. Pa. v. Casey</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=505%20us%20833&amp;summary=yes#jcite">505 U.S. 833</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=505%20us%20833&amp;summary=yes#jcite">896</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=112%20supreme%20court%202791&amp;summary=yes#jcite">112 S.Ct. 2791</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=120%20l%20ed%202d%20674&amp;summary=yes#jcite">120 L.Ed.2d 674</a> (1992) ("The effect of state regulation on a woman's
protected liberty is doubly deserving of scrutiny in such a case, as the
State has touched not only upon the private sphere of the family but upon
the very bodily integrity of the pregnant <span CLASS="page_no" data-cite="2012 bl 254593 p 15" data-cite-type="Bloomberg" data-cite-pageno="15" data-primary-citation="">[**15]</span> woman.") (citing <i>Cruzan</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=497%20us%20261&amp;summary=yes#jcite">497 U.S. at 281</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=110%20supreme%20court%202841&amp;summary=yes#jcite">110 S.Ct. 2841</a>).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  By making a bodily-integrity claim part and parcel with a right-to-privacy
claim, <i>Casey</i> and its progeny serve as the proper cases for examining
bodily-integrity claims in the abortion context. In light of these
abortion-specific cases applying the undue-burden framework, there is little
constitutional support for Planned Parenthood's attempt to return to the
stricter balancing standard used in traditional bodily-integrity claims.
Thus, the argument that the Ohio restrictions unduly impact a woman's right
to bodily integrity is a viable claim, but, from a purely legal perspective,
the analysis will map the undue-burden frame-work set out in Planned
Parenthood's third claim of constitutional infirmity.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>VI. UNDUE-BURDEN CLAIM</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>(Judge Moore's Partial Dissent)</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  "`[A] law designed to further the State's interest in fetal life which
imposes an undue burden on the woman's decision before fetal viability' is
unconstitutional." <i>Stenberg v. Carhart</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=530%20us%20914&amp;summary=yes#jcite">530 U.S. 914</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=530%20us%20914&amp;summary=yes#jcite">921</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=120%20supreme%20court%202597&amp;summary=yes#jcite">120 S.Ct. 2597</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=147%20l%20ed%202d%20743&amp;summary=yes#jcite">147 L.Ed.2d 743</a> (2000) (quoting <i>Casey</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=505%20us%20833&amp;summary=yes#jcite">505 U.S. at 877</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=112%20supreme%20court%202791&amp;summary=yes#jcite">112 S.Ct. 2791</a>).
"[U]ndue burden is . . . shorthand for the conclusion that a state
regulation has the purpose or effect of placing a substantial obstacle in
the path of a woman seeking an abortion of a nonviable fetus." <i>Casey</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=505%20us%20833&amp;summary=yes#jcite">505 U.S. at 877</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=112%20supreme%20court%202791&amp;summary=yes#jcite">112 S.Ct. 2791</a>. On summary judgment, we review the evidence
in the light most favorable to Planned Parenthood. When thus viewing the
evidence, I would hold that the State has failed to demonstrate an absence
of a genuine dispute of material fact regarding whether the Act imposes a
substantial obstacle in the path of Ohio women seeking to obtain an abortion
of a nonviable fetus. Summary judgment for the State was therefore
inappropriate as to this claim.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  A number of adverse effects<a HREF="#fn1700" name="fnref_fn1700">[fn17]</a> of the Act are undisputed. The Act (1)
requires additional
<span CLASS="page_no" data-cite="696 f 3d 508" data-cite-type="PrimaryFederalReporter" data-cite-pageno="508" data-primary-citation="696 F.3d 490">[*508]</span> 
clinical visits, potentially increasing costs and inconvenience; (2) the Act
requires a higher dosage of mifepristone, also increasing costs; and (3) the
Act makes mifepristone unavailable to women between 50 and 63 days LMP,
functioning as a total ban on medical abortions for these women and leaving
surgery as the only option for terminating their pregnancies. R. 161 (D. Ct.
5/23/11 Order at 27-28) (Page ID #2654-55). The first two effects relate to
the dosage and treatment protocols and do not constitute an outright ban on
any particular method. The district court concluded that these "may increase
the cost of the procedure," but under <i>Casey</i>, "the incidental effect of
making it more difficult or more expensive to procure an abortion cannot be
enough to invalidate" the law. <i>Id.</i> at 28. The third effect, the gestational
limit, amounts to a total ban on medical abortions for women between 50 and
63 days LMP. The district court concluded that this was not an undue burden
because "it is undisputed that the Act does not impact the[] ability to
choose a safe, commonly used method of abortion," i.e., a surgical abortion.
<i>Id.</i> The parties debate the meaning of "substantial obstacle," and I discuss
the proscriptions each in turn, starting with the total method ban for women
past 49 days LMP.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>A. Outright Ban on Medical Abortions During 50 to 63 Days LMP</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Supreme Court <span CLASS="page_no" data-cite="2012 bl 254593 p 16" data-cite-type="Bloomberg" data-cite-pageno="16" data-primary-citation="">[**16]</span> has not explicitly defined when a total method ban
constitutes a "substantial obstacle" to a woman's exercise of her rights.
Planned Parenthood argues that any regulation that prohibits a "commonly
used method" of abortion is a substantial obstacle and therefore imposes an
undue burden. The State argues that regulations banning a particular method
are a substantial obstacle only if they serve to inhibit the "vast majority"
of abortions such as by banning the "most common" procedure for obtaining
those abortions.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Supreme Court first addressed complete bans on a particular method in
<i>Planned Parenthood of Central Missouri v. Danforth</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=428%20us%2052&amp;summary=yes#jcite">428 U.S. 52</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=96%20supreme%20court%202831&amp;summary=yes#jcite">96 S.Ct. 2831</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=49%20l%20ed%202d%20788&amp;summary=yes#jcite">49 L.Ed.2d 788</a> (1976). <i>Danforth</i> struck down a law banning
"the use of a method which the record shows is the one most commonly used
nationally by physicians after the first trimester and which is safer, with
respect to maternal mortality, than even continuation of the pregnancy until
normal childbirth." <i>Id.</i> at 78, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=96%20supreme%20court%202831&amp;summary=yes#jcite">96 S.Ct. 2831</a>. <i>Casey</i> did not overrule
<i>Danforth</i>, and we have interpreted <i>Casey</i> as clarifying that before viability,
the question is "whether `in a large fraction of the cases in which [the
ban] is relevant, it will operate as a substantial obstacle to a woman's
choice to undergo an abortion.'" <i>Women's Med. Profl Corp. v. Voinovich</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=130%20f%203d%20187&amp;summary=yes#jcite">130 F.3d 187</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=130%20f%203d%20187&amp;summary=yes#jcite">196</a> (6th Cir.1997) (quoting <i>Casey</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=505%20us%20833&amp;summary=yes#jcite">505 U.S. at 895</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=112%20supreme%20court%202791&amp;summary=yes#jcite">112 S.Ct. 2791</a>), <i>cert. denied</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=523%20us%201036&amp;summary=yes#jcite">523 U.S. 1036</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=118%20supreme%20court%201347&amp;summary=yes#jcite">118 S.Ct. 1347</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=140%20l%20ed%202d%20496&amp;summary=yes#jcite">140 L.Ed.2d 496</a> (1998).<a HREF="#fn1800" name="fnref_fn1800">[fn18]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The only other previability method bans reviewed by the Supreme Court
involve partial-birth abortion techniques in the second trimester. In
<i>Stenberg</i>, similarly to <i>Danforth</i>, the Supreme Court held that
<span CLASS="page_no" data-cite="696 f 3d 509" data-cite-type="PrimaryFederalReporter" data-cite-pageno="509" data-primary-citation="696 F.3d 490">[*509]</span> 
because dilation and evacuation procedures ("D &amp; E") were "the most commonly
used method for performing previability second trimester abortions,"
Missouri's ban imposed "an undue burden upon a woman's right to make an
abortion decision" if it covered D &amp; E abortions. <i>Stenberg</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=530%20us%20914&amp;summary=yes#jcite">530 U.S. at 945-46</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=120%20supreme%20court%202597&amp;summary=yes#jcite">120 S.Ct. 2597</a>. The only issue in the case was the scope
of the statute &mdash; the state conceded that if the statute banned D &amp; E
abortions and not just the smaller subclass of dilation and extraction ("D &amp;
X") abortions, before viability, the statute imposed an undue burden on the
right to choose abortion. <i>Id.</i> at 938, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=120%20supreme%20court%202597&amp;summary=yes#jcite">120 S.Ct. 2597</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In <i>Gonzales</i>, the Supreme Court upheld a federal abortion ban because the
statute prohibited only D &amp; X abortions (called "intact D &amp; E" abortions in
the opinion), and the plaintiffs had failed to show "that the Act would be
unconstitutional in a large fraction of relevant cases." <i>Gonzales</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=550%20us%20124&amp;summary=yes#jcite">550 U.S. at 167-68</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=127%20supreme%20court%201610&amp;summary=yes#jcite">127 S.Ct. 1610</a>. Again, the Attorney General conceded
that "the Act would impose an undue burden if it covered standard D &amp; E."
<i>Id.</i> at 147, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=127%20supreme%20court%201610&amp;summary=yes#jcite">127 S.Ct. 1610</a>. Unlike in <i>Danforth</i>, "the [Partial-Birth Abortion
Ban] Act allows, among other means, a commonly used and generally accepted
method," a method that was almost identical from the patient's perspective
to the banned method, "so it does not construct a substantial obstacle to
the abortion right." <i>Id.</i> at 165, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=127%20supreme%20court%201610&amp;summary=yes#jcite">127 S.Ct. 1610</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This court has also addressed method bans similar to the ones in <i>Danforth,</i>
<i>Stenberg</i>, and <i>Gonzales.</i> In <i>Wolfe v. Schroering</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=541%20f%202d%20523&amp;summary=yes#jcite">541 F.2d 523</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=541%20f%202d%20523&amp;summary=yes#jcite">526</a> (6th
Cir.1976), we invalidated a Kentucky statute that was "virtually identical"
to the one struck down in <i>Danforth</i> because the "instant record reflects that
the saline method, at the enactment of the <span CLASS="page_no" data-cite="2012 bl 254593 p 17" data-cite-type="Bloomberg" data-cite-pageno="17" data-primary-citation="">[**17]</span> statutory prohibition, was the
only available method in Kentucky, thus making its prohibition `almost
tantamount' to a prohibition of post-first trimester abortions." <i>Id.</i> at
526-27. In <i>Voinovich</i>, we struck down an Ohio statute banning partial-birth
abortions as imposing an undue burden because the statute's plain meaning
included the D &amp; E method, "the most common method of abortion in the second
trimester." <i>Voinovich</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=130%20f%203d%20187&amp;summary=yes#jcite">130 F.3d at 201</a>; <i>see also Northland Family Planning</i>
<i>Clinic, Inc. v. Cox</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=487%20f%203d%20323&amp;summary=yes#jcite">487 F.3d 323</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=487%20f%203d%20323&amp;summary=yes#jcite">337</a> (6th Cir.2007) (striking down
Michigan law because unclear if statute banned D &amp; E abortions, which "would
prohibit several of the most common pre-viability abortion methods"), <i>cert.</i>
<i>denied</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=552%20us%201096&amp;summary=yes#jcite">552 U.S. 1096</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=128%20supreme%20court%20872&amp;summary=yes#jcite">128 S.Ct. 872</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=128%20supreme%20court%20872&amp;summary=yes#jcite">873</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=169%20l%20ed%202d%20725&amp;summary=yes#jcite">169 L.Ed.2d 725</a> (2008). In
<i>Women's Medical</i>, we affirmed the validity of a statute after determining
that the ban applied to D &amp; X abortions. "[B]ecause the Act does not
restrict the most commonly used procedure for second trimester abortions . .
. we conclude that it does not impose an undue burden on a woman's right to
abort a non-viable fetus." <i>Women's Med.</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=353%20f%203d%20436&amp;summary=yes#jcite">353 F.3d at 453</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  What these cases tell us is that, at the least, statutes banning the most
common method of an abortion impose an unconstitutional burden on a woman's
rights. The cases do not engage in a strict mathematical inquiry of
percentages to identify the frequence of a procedure, nor, as facial
challenges, do they demand affidavits from women indicating that they would
not obtain an abortion via some other lawful method if D &amp; E abortions were
made unavailable. We can safely presume that a statute banning the most
common method of abortions for a certain group of women imposes a
substantial obstacle on the ability of a woman to obtain an abortion. But
that does not tell us whether a ban on <i>any</i> common method could not also
constitute a
<span CLASS="page_no" data-cite="696 f 3d 510" data-cite-type="PrimaryFederalReporter" data-cite-pageno="510" data-primary-citation="696 F.3d 490">[*510]</span> 
"large fraction" under <i>Casey.</i><a HREF="#fn1900" name="fnref_fn1900">[fn19]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The State relies heavily on the use of the phrase "vast majority" in
Supreme Court jurisprudence when describing the most common method to
suggest that any common method can be banned so long as the most common
method remains. In <i>Gonzales</i>, the Supreme Court stated that the ban on D &amp; X
abortions "cannot be held invalid on its face" because the requirement would
not "prohibit the vast majority of D &amp; E abortions." <i>Gonzales</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=550%20us%20124&amp;summary=yes#jcite">550 U.S. at 156</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=127%20supreme%20court%201610&amp;summary=yes#jcite">127 S.Ct. 1610</a>. But we must be mindful of the factual
distinctions between such cases and ours. Neither we nor the Supreme Court
have addressed a ban on a method demonstrably preferred by, for example, a
third of similarly situated women, particularly when that method is highly
dissimilar from the remaining methods. Such a method may not be the "most
common," but one could easily classify a third as a "large fraction" or
decline to label the remaining method a "vast majority." When <i>Gonzales</i>
points to the existence of a "commonly used and generally accepted method"
as a reason for sustaining the ban, we must read this language in the
context of the methods being discussed. <i>Id.</i> at 165, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=127%20supreme%20court%201610&amp;summary=yes#jcite">127 S.Ct. 1610</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In <i>Gonzales</i>, the Supreme Court highlighted the similarities between D &amp; E
abortions and D &amp; X abortions, which the opinion even calls "intact D &amp; E"
abortions because they are a "D &amp; E variation." <i>Gonzales</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=550%20us%20124&amp;summary=yes#jcite">550 U.S. at 136-37</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=127%20supreme%20court%201610&amp;summary=yes#jcite">127 S.Ct. 1610</a>. Both D &amp; X and D &amp; E abortions involve
the same "general <span CLASS="page_no" data-cite="2012 bl 254593 p 18" data-cite-type="Bloomberg" data-cite-pageno="18" data-primary-citation="">[**18]</span> steps": dilating the cervix, inserting surgical
instruments into the woman, placing the woman under general anesthesia or
sedation, inserting forceps, and evacuating the fetus. <i>Id.</i> at 135-36,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=127%20supreme%20court%201610&amp;summary=yes#jcite">127 S.Ct. 1610</a>. The decision whether to perform a D &amp; X abortion or D &amp; E
abortion appears largely up to the physician and not the patient. <i>Id.</i> at
137, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=127%20supreme%20court%201610&amp;summary=yes#jcite">127 S.Ct. 1610</a>. The primary difference related to the destruction of
the fetus &mdash; D &amp; X abortions resemble a live birth because the fetus is
removed almost entirely and terminated outside the womb rather than
termination during (or even before) the procedure itself.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The frequency of the D &amp; X method, although statistically unclear with any
certainty, was also very infrequent relative to standard D &amp; E abortions.
The Supreme Court referenced the district court opinion for many of its
facts, which noted that most doctors reported D &amp; X abortions occurring in
five to fifteen percent of all D &amp; E procedures; D &amp; E abortions as a whole,
depending on the gestational age, constituted between eighty-five to
ninety-five percent of second-trimester abortions. <i>See Planned Parenthood</i>
<i>Fed'n of Am. v. Ashcroft</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=320%20f%20supp%202d%20957&amp;summary=yes#jcite">320 F.Supp.2d 957</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=320%20f%20supp%202d%20957&amp;summary=yes#jcite">965</a> (N.D.Cal. 2004), <i>as cited</i>
<i>by Gonzales</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=550%20us%20124&amp;summary=yes#jcite">550 U.S. at 155</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=127%20supreme%20court%201610&amp;summary=yes#jcite">127 S.Ct. 1610</a>. The banned procedure therefore
only affected (at most) fourteen percent of women in those gestational
ranges. Given the infrequency of the procedure being analyzed in <i>Gonzales</i>
and subsequent cases, the language in <i>Gonzales</i> does not suggest that the
Supreme Court would reach the same result for a ban of a method chosen in
thirty-one percent of first-trimester abortions, particularly where the
differences in the available procedures make it difficult for us to assume
<span CLASS="page_no" data-cite="696 f 3d 511" data-cite-type="PrimaryFederalReporter" data-cite-pageno="511" data-primary-citation="696 F.3d 490">[*511]</span> 
that the methods are interchangeable from the perspective of the female.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  With that in mind, I turn to the facts of this case. When viewed in the
light most favorable to Planned Parenthood, the evidence suggests that
medical abortions were elected over surgical abortions on average by about
thirty-one percent of Planned Parenthood's patients in 2009. The State
reminds us that Planned Parenthood is not the only abortion provider in
Ohio, but even the State's number, that 17.7% of cases in 2008 were
medical/non-surgical, is a non-trivial percentage. And, in the very study
cited by the State for its statistic, the Ohio Department of Health observed
that FDA approval of mifepristone "was expected to shift many of the early
abortions from surgical to non-surgical methods." OHIO DEPAETMENT OF HEALTH,
INDUCED ABORTIONS IN OHIO (2008), <i>available online at</i>
http://www.odh.ohio.gov/healthstats/vitalstats/abortion mainpage.aspx.
Indeed, by 2010, that same category had increased to 20 percent.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We should not expect Planned Parenthood to present specific numbers of
women who would not have obtained a surgical abortion at all had the medical
abortion been unavailable. As an initial matter, the Act was not enforced in
Ohio until February 2011 when the district court clarified the scope of the
preliminary injunction. Planned Parenthood suspended the provision of
medical abortions at its Ohio clinics in January 2011. <i>See, e.g.</i>, R. 153-1
(2d Brenner Decl. at &para; 3) (Page ID #<span CLASS="page_no" data-cite="2012 bl 254593 p 19" data-cite-type="Bloomberg" data-cite-pageno="19" data-primary-citation="">[**19]</span> 2535). Since then, Planned Parenthood
had to deny medical abortions to between 50 and 100 women. R. 153 (Pls.'
Mem. Prelim. Inj. at 4) (Page ID #2516). The majority fixates on the
affidavits of nine of those women who testified that they thereafter
obtained a surgical abortion, despite the extra anxiety and pain it caused
them, as conclusively establishing as a matter of law that the method ban in
this case does not impose a substantial obstacle in a large fraction of
women. But women deterred by the ban who decided not to obtain any abortion
at all would be unlikely to return to Planned Parenthood's clinics or
volunteer to give their names or testimony.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  More importantly, the majority points to no case either from our court or
the Supreme Court requiring affirmative testimony from individual women that
they would not have obtained an abortion but for the ban to establish that a
total method ban imposes a substantial obstacle. <i>See Stenberg</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=530%20us%20914&amp;summary=yes#jcite">530 U.S. 914</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=120%20supreme%20court%202597&amp;summary=yes#jcite">120 S.Ct. 2597</a> (not considering whether women could just as easily obtain an
abortion using alternative method if D &amp; E method were banned); <i>Danforth</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=428%20us%2052&amp;summary=yes#jcite">428 U.S. at 75-76</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=96%20supreme%20court%202831&amp;summary=yes#jcite">96 S.Ct. 2831</a> (same for saline amniocentesis
method).<a HREF="#fn2000" name="fnref_fn2000">[fn20]</a> Planned Parenthood's facial challenge to the Act, which was
first filed in 2004 before the Act was ever enforced, does not rely on the
sort of as-applied testimony that the dissent seeks. As discussed above, it
is hard to imagine how Planned Parenthood would even gather such data. That
difficulty will be present in many cases and cannot be a reasoned basis for
ignoring the potential burdens of the Act on a woman's constitutional
rights.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Nor has the Supreme Court defined "substantial obstacle" as requiring a
showing of a <i>total</i> obstacle. Just by examining the physical differences
between the methods, our common sense tells us that the differences between
the procedures from the perspective of the woman are substantial. Surgical
abortions, as the name suggests, require surgery, a physically invasive
procedure, including
<span CLASS="page_no" data-cite="696 f 3d 512" data-cite-type="PrimaryFederalReporter" data-cite-pageno="512" data-primary-citation="696 F.3d 490">[*512]</span> 
sedation and potentially even general anesthesia, and a procedure in the
sterile environment of an outpatient clinic. Medical abortions, on the other
hand, consist primarily of ingesting pills and terminating the pregnancy in
the privacy of the woman's home. Three years ago, almost a third of women
chose this second method. We simply should not conclude as a matter of law
that every woman who would prefer a medical abortion would be equally likely
to obtain a surgical abortion on the basis of nine affidavits. These are
questions of fact ill-suited for resolution on summary judgment.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  At the very least, the frequency of medical abortions among women prevents
us from concluding as a matter of law that medical abortions do not
constitute a "large fraction" among women within the specific gestational
time frame banned by the Act &mdash; 50 to 63 days LMP. The sheer fact that
roughly a third of Planned Parenthood's patients have elected a medical
abortion over a surgical abortion suggests that eliminating medical
abortions may cause a large fraction of women to forego having an abortion
altogether. The State'<span CLASS="page_no" data-cite="2012 bl 254593 p 20" data-cite-type="Bloomberg" data-cite-pageno="20" data-primary-citation="">[**20]</span> s own statistics suggest a rise in popularity of this
procedure, and the Supreme Court itself has acknowledged that the most
common procedure can change over time. <i>Stenberg</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=530%20us%20914&amp;summary=yes#jcite">530 U.S. at 924</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=120%20supreme%20court%202597&amp;summary=yes#jcite">120 S.Ct. 2597</a>. The parties should be permitted to present expert testimony
on the subject in order to understand better whether this case really is
similar to the method ban affirmed in <i>Gonzales</i> or is a different creature
entirely. We therefore cannot conclude as a matter of law that the existence
of surgical abortions for women between 50 and 63 days LMP makes Ohio's ban
on all medical abortions during that time frame constitutional. For all
these reasons, I dissent from the majority view expressed in Judge
McKeague's opinion.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>B. Restrictions on Dosage and Treatment Protocols</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  That brings us to the restrictions that the Act imposes on medical
abortions during the first 49 days LMP. "[N]ot every law which makes a right
more difficult to exercise is, <i>ipso facto</i>, an infringement of that right."
<i>Casey</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=505%20us%20833&amp;summary=yes#jcite">505 U.S. at 873</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=112%20supreme%20court%202791&amp;summary=yes#jcite">112 S.Ct. 2791</a>. The parties generally agree that
Planned Parenthood must show that the restrictions in the Act must have more
than just "the incidental effect of making it more difficult or more
expensive to procure an abortion." <i>Id.</i> at 874, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=112%20supreme%20court%202791&amp;summary=yes#jcite">112 S.Ct. 2791</a> (upholding
24-hour waiting period as not a substantial burden); <i>Wolfe</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=541%20f%202d%20523&amp;summary=yes#jcite">541 F.2d at 526</a>
(same because does not "significantly burden[] the abortion process.").
<i>Casey</i> also affirmed additional reporting requirements, because "[a]t most
they might increase the cost of some abortions by a slight amount. While at
some point increased cost could become a substantial obstacle, there is no
such showing on the record before us." <i>Casey</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=505%20us%20833&amp;summary=yes#jcite">505 U.S. at 901</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=112%20supreme%20court%202791&amp;summary=yes#jcite">112 S.Ct. 2791</a> (rejecting district court finding that added costs of travel
time and potentially lodging from requiring a 24-hour waiting period were a
substantial obstacle); <i>see also Planned Parenthood Ass'n of Kansas City,</i>
<i>Mo., Inc. v. Ashcroft</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=462%20us%20476&amp;summary=yes#jcite">462 U.S. 476</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=462%20us%20476&amp;summary=yes#jcite">486</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=462%20us%20476&amp;summary=yes#jcite">490</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=103%20supreme%20court%202517&amp;summary=yes#jcite">103 S.Ct. 2517</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=76%20l%20ed%202d%20733&amp;summary=yes#jcite">76 L.Ed.2d 733</a> (1983) (holding no undue burden in law requiring tissue
sample be taken during abortion because cost increased by only twenty
dollars and state imposed requirement in all surgeries to ensure safety).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In light of these cases, I agree with the district court that requiring a
third doctor's visit adds an insubstantial cost to procuring a medical
abortion. The extra visit appears no different from the extra visit caused
by a 24-hour waiting period, which the Supreme Court has explicitly
<span CLASS="page_no" data-cite="696 f 3d 513" data-cite-type="PrimaryFederalReporter" data-cite-pageno="513" data-primary-citation="696 F.3d 490">[*513]</span> 
deemed a valid regulation. I cannot say that the same is true for the dosage
requirements, however. The district court concluded that there is little
evidence to suggest that any women before 49 days LMP will be deterred from
obtaining an abortion because of the dosage and treatment restrictions on a
medical abortion. R. 161 (D. Ct. 5/23/11 Order at 29) (Page ID # 2656). But
on summary judgment, we must view the record in the light most favorable to
Planned Parenthood. Planned Parenthood offered testimony that the
FDA-protocol's usage of 600 mg of mifepristone would increase the cost of an
abortion by $150, a significant increase over what it otherwise costs
patients, over forty percent in some clinics. We have no way of knowing if
these women are the exception <span CLASS="page_no" data-cite="2012 bl 254593 p 21" data-cite-type="Bloomberg" data-cite-pageno="21" data-primary-citation="">[**21]</span> or the rule, because the resolution of these
questions is usually done after the consideration of testimony and evidence.
<i>See Cincinnati Women's Servs., Inc. v. Taft</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=468%20f%203d%20361&amp;summary=yes#jcite">468 F.3d 361</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=468%20f%203d%20361&amp;summary=yes#jcite">369</a> (6th
Cir.2006) (emphasizing need to examine closely factual record).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The majority again feels comfortable resolving these fact questions on
summary judgment against Planned Parenthood due to the price difference
between surgical abortions and medical abortions. But the majority ignores
the fact that the very reason surgical abortions are now less expensive is
because the Act requires the medical abortions to use more medicine. Again,
a "substantial obstacle" has never been defined as a total obstacle. And in
evaluating the impact of restrictions, rarely do courts rely exclusively on
percentages. <i>See id.</i> at 374 ("[T]he term `large fraction,' which, in a way,
is more conceptual than mathematical, envisions something more than the 12
out of 100 women identified here."); <i>Planned Parenthood, Sioux Falls Clinic</i>
<i>v. Miller</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=63%20f%203d%201452&amp;summary=yes#jcite">63 F.3d 1452</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=63%20f%203d%201452&amp;summary=yes#jcite">1459-63</a> (8th Cir.1995) (holding parental
notification laws unduly burdened a "large fraction" without attempting to
quantify the number of minors affected by provision; treating "substantial
obstacle" as the "possibility of such obstruction &mdash; or even attempted
obstruction" and not a guaranteed inability to obtain an abortion), <i>cert.</i>
<i>denied</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=517%20us%201174&amp;summary=yes#jcite">517 U.S. 1174</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=116%20supreme%20court%201582&amp;summary=yes#jcite">116 S.Ct. 1582</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=134%20l%20ed%202d%20679&amp;summary=yes#jcite">134 L.Ed.2d 679</a> (1996); <i>see also</i>
<i>Casey</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=505%20us%20833&amp;summary=yes#jcite">505 U.S. at 894-95</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=112%20supreme%20court%202791&amp;summary=yes#jcite">112 S.Ct. 2791</a> (striking down
spousal-notification law because within group of affected women, which was
only one percent of the whole, a "large fraction" would be deterred by the
notification laws based not on specific affidavits or percentages but on
evidence of the "persisting conditions" explaining why such women might be
deterred).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The extent of the Act's burden on a woman's constitutional rights, as it
relates to the gestational limits and the dosage requirements, is a
genuinely disputed issue of material fact not ripe for summary judgment in
this case. Therefore, I dissent from the contrary view expressed in Judge
McKeague's majority opinion.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>VII. CONCLUSION</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  For the reasons expressed in Parts I through V and in Judge McKeague's
opinion, the judgment of the district court is <b>AFFIRMED.</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn100" name="fn100">[fn1]</a></span> The State objects to the admissibility of the declaration of Dr.
Maureen Paul. The district court has not yet ruled on the admissibility of
her testimony, and we take no position on this evidentiary matter. We cite
only her statements that are undisputed by the State.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn200" name="fn200">[fn2]</a></span> The Act does not explicitly ban or regulate the <i>prescription</i> of
misoprostol, which has not been approved by the FDA for use in abortions,
although it has been FDA approved for the treatment of ulcers.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn300" name="fn300">[fn3]</a></span> The main FDA documents were filed before the district court on
plaintiffs' motion for a permanent injunction, which were then submitted to
this panel as a Joint Appendix in the prior appeal. The exhibits were
resubmitted by the parties to the district court for consideration on the
summary-judgment motions; for ease of reference, we continue to cite the
prior Joint Appendix to the extent that the parties relied on the same
exhibits in support of summary judgment.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn400" name="fn400">[fn4]</a></span> The FDA regulates the marketing and distribution of drugs by
manufacturers, not the practices of physicians in treating patients.
However, manufacturers can apply to the FDA to update a drug's approval
letter based on new studies. That has not been done in this case.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn500" name="fn500">[fn5]</a></span> Because the FDA protocol stops at 49 days LMP, all of the women
between 49 and 63 days LMP would be using a non-FDA protocol regarding the
gestational time limits and presumably the dosages would also mirror a
non-FDA protocol as a result.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn600" name="fn600">[fn6]</a></span> The State responds that Planned Parenthood may very well have
recommended that its patients choose an alternative regimen.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn700" name="fn700">[fn7]</a></span> Clawson estimated an increase in cost from $410 to $700 when the extra
medication as well as the extra clinic visit are both considered. R. 134-4
(Clawson Decl. &para; 12) (Page ID #2151).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn800" name="fn800">[fn8]</a></span> Medical abortions may also be performed using just a high dose of
misoprostol, or by using the drug methotrexate in combination with
misoprostol. The parties debate the safety, prevalence, and efficacy of
these alternative medical abortions, but do not dispute that neither
misoprostol nor methotrexate has been approved by the FDA for use in
abortions. Planned Parenthood has a nationwide policy of not offering
medical abortions with methotrexate because of the lack of medical evidence
on its safety. At the preliminary injunction hearing, the plaintiffs' expert
testified that methotrexate poses greater health risks than mifepristone
when used for medical abortions, and we have previously determined this to
be a fact that the State did not contest. <i>Taft II</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=444%20f%203d%20502&amp;summary=yes#jcite">444 F.3d at 512</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn900" name="fn900">[fn9]</a></span> The 2010 version of that same report, also publicly available online
at http://www.odh.ohio.gov/healthstats/vitalstats/abortion mainpage.aspx,
indicates that the percentage of medical/non-surgical abortions increased to
20%.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1000" name="fn1000">[fn10]</a></span> Planned Parenthood rejects the State's argument that this shows the
FDA plan is safer, noting that the statistic is also explained by the
overall prevalence of the alternative regimen over the FDA protocols.
Appellant Br. at 15 &amp; n. 8.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1100" name="fn1100">[fn11]</a></span> Bob Taft was the Governor of Ohio at the time, succeeded by Ted
Strickland. The parties have since stipulated to the dismissal of the
Governor. Appellant Br. at 3 n. 2. The lead defendant is now Ohio's Attorney
General, Mike DeWine.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1200" name="fn1200">[fn12]</a></span> On remand, the district court also clarified the scope of the
preliminary injunction to prohibit enforcement of the Act "only insofar as
it prohibits off-label mifepristone abortions that are `necessary, in
appropriate medical judgment, for the preservation of the life or health of
the mother.'" <i>Planned Parenthood Cincinnati Region v. Dewine</i>, No.
1.04-CV-493, 2011 WL 463093, at *1 (S.D.Ohio Feb. 4, 2011) (quoting <i>Taft II</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=444%20f%203d%20502&amp;summary=yes#jcite">444 F.3d at 511</a>). Pursuant to the district court's revised preliminary
injunction, the Act may now be enforced in all other circumstances.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1300" name="fn1300">[fn13]</a></span> Indeed, in the context of res judicata where a similar inquiry
regarding "operative facts" is frequently made, the Seventh Circuit has
advised that "courts should examine the `facts' of a case at a sufficient
level of specificity" and not consider them too broadly or too narrowly when
identifying individual transactions, defined as "a single core of operative
facts which give rise to a remedy." <i>Andersen v. Chrysler Corp.</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=99%20f%203d%20846&amp;summary=yes#jcite">99 F.3d 846</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=99%20f%203d%20846&amp;summary=yes#jcite">852-53</a> (7th Cir.1996); <i>see also</i> 18 CHARLES ALAN WRIGHT, ARTHUR R. MILLER &amp;
EDWARD H. COOPER, FEDERAL PRACTICE AND PROCEDURE &sect; 4407 (2d ed. 2002)
(discussing "claims" for res judicata purposes).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1400" name="fn1400">[fn14]</a></span> The lead opinion in <i>Cordray</i> is only a plurality; however, a majority
of justices joined the syllabus and the judgment, which clearly incorporated
the final printed labeling's gestational limits, treatment protocols, and
dosage indications into the FDA approval letter. <i>Cordray</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=911%20north%20eastern%202d%20871&amp;summary=yes#jcite">911 N.E.2d at 873</a>.
The parties both cite the plurality opinion as the opinion of the Ohio
Supreme Court, and we will rely on it as well. A plurality opinion still
offers useful guidance on how a state court is likely to interpret a state
statute, and, as a federal court interpreting state law, we are obligated to
respect that guidance. <i>Cf. West</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=311%20us%20223&amp;summary=yes#jcite">311 U.S. at 236-37</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=61%20supreme%20court%20179&amp;summary=yes#jcite">61 S.Ct. 179</a>
(counseling federal courts additionally to consider accepted rules of
inferior state courts when elucidating state law).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1500" name="fn1500">[fn15]</a></span> The opinion also references "three office visits," defeating Planned
Parenthood's argument that the Act is unclear regarding whether the
misoprostol can be administered at home; it cannot. <i>Cordray</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=911%20north%20eastern%202d%20871&amp;summary=yes#jcite">911 N.E.2d at 874</a> (" [T]reatment with mifepristone requires three office
visits by the patient. . . . On day three, the patient returns to the
provider for an oral dose of 400 jxg of misoprostol.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1600" name="fn1600">[fn16]</a></span> Bodily integrity claims have occasionally been given strict-scrutiny
review by the lower courts. <i>Kallstrom v. City of Columbus</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=136%20f%203d%201055&amp;summary=yes#jcite">136 F.3d 1055</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=136%20f%203d%201055&amp;summary=yes#jcite">1064</a> (6th Cir.1998) (reviewing with strict scrutiny a claim that release of
private information threatened individual's personal security and bodily
integrity).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1700" name="fn1700">[fn17]</a></span> Although <i>Casey</i> discusses the "purpose or effect" of the challenged
legislation, Planned Parenthood does not attempt to argue that Ohio had an
illicit purpose in passing the Act and focuses solely on the Act's effects.
The fact that the Act focuses solely on abortions (and not other off-label
uses of mifepristone) certainly raises some eyebrows, but we will not
presume a harmful purpose without evidence of an illicit motive. <i>Mazurek v.</i>
<i>Armstrong</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=520%20us%20968&amp;summary=yes#jcite">520 U.S. 968</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=520%20us%20968&amp;summary=yes#jcite">972</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=117%20supreme%20court%201865&amp;summary=yes#jcite">117 S.Ct. 1865</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=138%20l%20ed%202d%20162&amp;summary=yes#jcite">138 L.Ed.2d 162</a> (1997).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1800" name="fn1800">[fn18]</a></span> <i>Casey</i> itself was not a method-ban case and analyzed whether certain
restrictions such as informed-consent and spousal-notification laws
constituted an undue burden. <i>Casey</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=505%20us%20833&amp;summary=yes#jcite">505 U.S. at 895</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=112%20supreme%20court%202791&amp;summary=yes#jcite">112 S.Ct. 2791</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1900" name="fn1900">[fn19]</a></span> The State seizes on the fact that we later repeated the "most
common[]" language when discussing a state ban on D &amp; X procedures, <i>see</i>
<i>Women's Med.</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=353%20f%203d%20436&amp;summary=yes#jcite">353 F.3d at 453</a>, but we were engaged solely in the task of
statutory construction, not in determining whether D &amp; X abortions
constituted a large fraction (because <i>Gonzales</i> had just held that it did
not). <i>See also Voinovich</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=130%20f%203d%20187&amp;summary=yes#jcite">130 F.3d at 201</a> ("[I]t follows that a statute
which bans a common abortion procedure would constitute an undue burden.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn2000" name="fn2000">[fn20]</a></span> I therefore reject the State's position that Planned Parenthood must
explicitly "quantify the number of women deterred" in order to make its
case. Appellee Br. at 47 n. 7.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  McKEAGUE, Circuit Judge, concurring in part and writing the majority as to
Part VI.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I agree with Judge Moore's opinion as to parts I-V. I write separately
with regard to Planned Parenthood's undue burden claim because, as Judge
Dlott's well-reasoned opinion stated: "Even viewing the evidence in the
light most favorable to [Planned Parenthood], it is clear that the record
does not create a triable issue of material fact as to whether the Act has
the effect of creating a substantial
<span CLASS="page_no" data-cite="696 f 3d 514" data-cite-type="PrimaryFederalReporter" data-cite-pageno="514" data-primary-citation="696 F.3d 490">[*514]</span> 
obstacle to the abortion right. There is no evidence that the Act would
impose an undue burden on `a woman's ability to make th[e] decision to have
an abortion.'" (Order Granting in Part Mot. Sum. J. at 28, Page ID # 2655
(quoting <i>Planned Parenthood Se. Penn. v. Casey</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=505%20us%20833&amp;summary=yes#jcite">505 U.S. 833</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=505%20us%20833&amp;summary=yes#jcite">874</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=112%20supreme%20court%202791&amp;summary=yes#jcite">112 S.Ct. 2791</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=120%20l%20ed%202d%20674&amp;summary=yes#jcite">120 L.Ed.2d 674</a> (1992) (second alteration in original))).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As Judge Moore's opinion correctly notes, we must view the inferences to
be drawn from the underlying facts in the light most favorable to Planned
Parenthood. <i>See Matsushita Elec. Indus. Co., Ltd. v. Zenith Radio <span CLASS="page_no" data-cite="2012 bl 254593 p 22" data-cite-type="Bloomberg" data-cite-pageno="22" data-primary-citation="">[**22]</span> Corp.</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=475%20us%20574&amp;summary=yes#jcite">475 U.S. 574</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=475%20us%20574&amp;summary=yes#jcite">587</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=106%20supreme%20court%201348&amp;summary=yes#jcite">106 S.Ct. 1348</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=89%20l%20ed%202d%20538&amp;summary=yes#jcite">89 L.Ed.2d 538</a> (1986). The two parts of
the Act that Planned Parenthood claims create an undue burden discussed here
are: (1) the ban on medical abortions between 50 and 63 days LMP, and (2)
the increased dosage requirements. Review of the evidence shows that the
district court correctly concluded that the record simply does not give rise
to a reasonable inference that the Act imposes a substantial obstacle for
Ohio women deciding whether to abort a pregnancy. Therefore, these claims
cannot survive summary judgment.<a HREF="#fn101" name="fnref_fn101">[fn1]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>A. Method Ban on Medical Abortions 50-63 days LMP</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  It is true that governing case law analyzing method bans in the context of
"partial-birth" techniques does not provide controlling guidance for this
case. At most, the Supreme Court in <i>Gonzales v. Carhart</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=550%20us%20124&amp;summary=yes#jcite">550 U.S. 124</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=550%20us%20124&amp;summary=yes#jcite">150-54</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=127%20supreme%20court%201610&amp;summary=yes#jcite">127 S.Ct. 1610</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=167%20l%20ed%202d%20480&amp;summary=yes#jcite">167 L.Ed.2d 480</a> (2007), instructed that state action
is likely to constitute an undue burden where the most common abortion
technique available to a particular subset of women is prohibited. Likewise,
our case law indicates a statute that "restrict[s] the most commonly used
procedure" is likely to be problematic. <i>Women's Med. Prof. Corp. v. Taft</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=353%20f%203d%20436&amp;summary=yes#jcite">353 F.3d 436</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=353%20f%203d%20436&amp;summary=yes#jcite">453</a> (6th Cir.2003). So if this case involved a method ban on
surgical abortion, which is the most common procedure at 50-63 days LMP, but
left open the option of medical abortion, <i>Gonzales</i> would dictate the result.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  But here, viewing the evidence in the light most favorable to Planned
Parenthood, we examine a method preferred by approximately 31% of women to
whom it is available. Because jurisprudence from the Supreme Court and this
Circuit does not clearly address a method ban comparable to the instant one,
we are left to apply the more general undue-burden standard. Thus, for
Planned Parenthood to survive summary judgment, there must be a genuine
dispute of material fact as to whether "`in a large fraction of the cases in
which [the Act] is relevant, it will operate as a substantial obstacle to a
woman's choice to undergo an abortion.'" <i>Women's Med. Prof. Corp. v.</i>
<i>Voinovich</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=130%20f%203d%20187&amp;summary=yes#jcite">130 F.3d 187</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=130%20f%203d%20187&amp;summary=yes#jcite">196</a> (6th Cir.1997) (quoting <i>Casey</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=505%20us%20833&amp;summary=yes#jcite">505 U.S. at 895</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=112%20supreme%20court%202791&amp;summary=yes#jcite">112 S.Ct. 2791</a>).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Importantly, the Supreme Court has not articulated any rule that would
suggest that the right to choose abortion encompasses the right to choose a
particular
<span CLASS="page_no" data-cite="696 f 3d 515" data-cite-type="PrimaryFederalReporter" data-cite-pageno="515" data-primary-citation="696 F.3d 490">[*515]</span> 
abortion method. In one dissenting opinion, Justice Stevens suggested that a
woman's constitutionally protected liberty interest in the right to choose
an abortion has "two components &mdash; her decision to terminate the pregnancy
and her decision concerning the method of doing so." <i>Benten v. Kessler</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=505%20us%201084&amp;summary=yes#jcite">505 U.S. 1084</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=505%20us%201084&amp;summary=yes#jcite">1085</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=112%20supreme%20court%202929&amp;summary=yes#jcite">112 S.Ct. 2929</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=120%20l%20ed%202d%20926&amp;summary=yes#jcite">120 L.Ed.2d 926</a> (1992) (per curiam)
(Stevens, J., dissenting) (holding &mdash; less than one month after <i>Casey</i> &mdash; that
a woman who had mifepristone pills confiscated before the FDA approved the
drug could not compel the agency to return her dose because she had not
demonstrated a substantial likelihood of success on the merits but declining
to reach the undue-burden issue, stating "we express no view on the merits
of this assertion"). But the Court has not expressly endorsed an approach
that would protect the right to choose <i>a particular method</i> of abortion. <i>See</i>
<i>Casey</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=505%20us%20833&amp;summary=yes#jcite">505 U.S. at 874</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=112%20supreme%20court%202791&amp;summary=yes#jcite">112 S.Ct. 2791</a> ("`the [abortion] right protects the
woman from unduly burdensome interference with her freedom <span CLASS="page_no" data-cite="2012 bl 254593 p 23" data-cite-type="Bloomberg" data-cite-pageno="23" data-primary-citation="">[**23]</span> to decide whether
to terminate her pregnancy.'" (quoting <i>Maker v. Roe</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=432%20us%20464&amp;summary=yes#jcite">432 U.S. 464</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=432%20us%20464&amp;summary=yes#jcite">473-74</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=97%20supreme%20court%202376&amp;summary=yes#jcite">97 S.Ct. 2376</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=53%20l%20ed%202d%20484&amp;summary=yes#jcite">53 L.Ed.2d 484</a> (1977))).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Planned Parenthood submitted a list of disputed issues of material fact in
opposition to summary judgment. Assuming the evidence therein is admissible,
the organization alleges that "first trimester surgical abortion is an
invasive procedure that many women seek to avoid" and that abortion is an
emotional procedure and there are many factors that affect the particular
procedure a woman may elect. (Plaintiffs Resp. to Ohio's Prop. Undisputed
Facts, Page ID #2072.) The organization also submits that "[o]nce women are
counseled about both medication and surgical abortion, most women
demonstrate a strong and clear preference for the type of procedure [that
they] choose and are satisfied with that method." (<i>Id.</i> at Page ID # 2073.)
Some of the specific reasons that Planned Parenthood says "[w]omen choose
medication" are a higher degree of personal control, the feeling that a
medical abortion is more natural, and the ability to execute a medical
abortion in the privacy of the woman's home. (<i>Id.</i>) Finally, Planned
Parenthood states "for victims of rape, or for women who have experienced
sexual abuse or molestation, medication abortion is often less traumatic . .
. [and] many women simply fear invasive surgery. . . . "(<i>Id.</i>)
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Planned Parenthood also offered the affidavits of nine women, some of whom
had their scheduled medication abortion cancelled because of the Act. For
example, one woman stated she was upset and sad because she felt a medical
abortion was more natural, but she had scheduled a surgical abortion anyway.
(Dawn Doe Aff., Page ID # 2574-75.) Another woman said that her daughter
"wanted her abortion experience to be the least invasive possible, and
wanted to have the abortion in the privacy of our home." (Leslie Doe Aff.,
Page ID # 2558.) When the medical abortion was cancelled, her daughter went
forward with the surgical procedure on the scheduled day. (<i>Id.</i> at Page ID #
2559.) She added that her daughter was "nervous and scared [about the
surgical procedure], and at the same time relieved that she was going to
terminate the pregnancy." (<i>Id.</i>) Another woman said that she was "shocked by
the news and scared" about the surgical procedure, but decided to go ahead
with it on the scheduled day. (Maria Doe Aff., Page ID #2653.) Another woman
said she felt "very frustrated and exasperated with the situation" but
"decided to go ahead with the surgical procedure that day." (Doreen Doe
Aff., Page ID # 2555.)
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  All of these statements <i>give</i> rise to the inference that some women prefer
a medical
<span CLASS="page_no" data-cite="696 f 3d 516" data-cite-type="PrimaryFederalReporter" data-cite-pageno="516" data-primary-citation="696 F.3d 490">[*516]</span> 
abortion over a surgical abortion, but they do not support the conclusion
that the unavailability of a medical abortion would create a <i>substantial</i>
<i>obstacle</i> for a large fraction of women in deciding whether to have an
abortion. Indeed, as Judge Dlott pointed out, the evidence shows that all of
the affected women who gave statements proceeded to obtain a surgical
abortion regardless of their preference for a medical procedure. Based on
this record, we cannot assume that Planned Parenthood will produce different
evidence at trial that <span CLASS="page_no" data-cite="2012 bl 254593 p 24" data-cite-type="Bloomberg" data-cite-pageno="24" data-primary-citation="">[**24]</span> could support this material fact. Such an assumption
would overstep the reasonable inferences we are meant to draw in the
organization's favor. <i>See Matsushita</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=475%20us%20574&amp;summary=yes#jcite">475 U.S. at 587</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=106%20supreme%20court%201348&amp;summary=yes#jcite">106 S.Ct. 1348</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I agree with the commonsense inference that because "the differences
between the procedures from the perspective of the woman are substantial,"
some &mdash; maybe even most &mdash; women will prefer medical abortion over surgical
abortion. <i>See ante</i> at &para; 56. However, our consideration cannot end there. The
abortion right as it has been described by the Supreme Court protects the
"freedom to decide whether to terminate" a pregnancy. <i>Casey</i>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=505%20us%20833&amp;summary=yes#jcite">505 U.S. at 874</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=112%20supreme%20court%202791&amp;summary=yes#jcite">112 S.Ct. 2791</a>. The Court has not extended constitutional
protection to a woman's preferred method, or her "decision concerning the
method" of terminating a pregnancy. <i>Benten</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=505%20us%201084&amp;summary=yes#jcite">505 U.S. at 1085</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=112%20supreme%20court%202929&amp;summary=yes#jcite">112 S.Ct. 2929</a>
(Stevens, J., dissenting). Therefore, without any evidence that the Act is a
substantial obstacle to the ultimate abortion decision, our own commonsense
conclusions about what women may prefer do not create a genuine dispute of
material fact.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Accordingly, the district court properly granted summary judgment with
regard to the method ban for women 50-63 days LMP.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>B. Increased Dosage</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court also properly found that Planned Parenthood failed to
allege sufficient evidence to survive summary judgment on its claim that the
added cost associated with increased dosage under the Act creates an undue
burden.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Planned Parenthood alleges a "significant" increase in the cost of a
medical abortion due to the increased dosage of mifepristone required by the
Act. (Plaintiffs Resp. to Ohio's Prop. Undisputed Facts, Page ID # 2072.)
More concretely, the organization submitted affidavits from clinic directors
indicating an increase of $150. (<i>See, e.g.</i>, Harrington Aff. &para; 8, Page ID
#2180; Brenner Aff. &para; 9, Page ID # 2114.) Viewing the evidence submitted in
the light most favorable to the organization, that would constitute an
increase of more than 40% over what medical abortion currently costs. (<i>See</i>
Harrington, Page ID # 2180.) Notably, before the Act, surgical abortion was
offered at the same price as medical abortion in all of the clinics that
submitted affidavits. (<i>See id.</i> (both procedures currently cost $360);
Brenner, Page ID # 2114 (both procedures currently cost $545); Clawson Aff.
&para; 12, Page ID # 2151 (both procedures currently cost $410); Lonn Aff. &para; 9,
Page ID # 2186 (both procedures currently cost $450)). So, unless the cost
of surgical abortion is independently raised, the alleged increased cost of
medical abortion would make surgical abortion a less-expensive option.
Planned Parenthood also submitted the affidavit of a woman who stated: "If a
medication abortion were offered at a price that was $100-$200 higher than a
surgical abortion, it would be really difficult for me. I am not certain I
would be able to still choose medication, though I would try to raise more
money, because it would be worth a lot to me." (Emily Poe Aff., Page ID #
2565.)
<span CLASS="page_no" data-cite="696 f 3d 517" data-cite-type="PrimaryFederalReporter" data-cite-pageno="517" data-primary-citation="696 F.3d 490">[*517]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Although the Supreme Court has indicated that "at some point, increased
cost could become a substantial obstacle," <i>Casey</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=505%20us%20833&amp;summary=yes#jcite">505 U.S. at 901</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=112%20supreme%20court%202791&amp;summary=yes#jcite">112 S.Ct. 2791</a>, that "point" remains undefined. In <i>Casey</i>, the evidence
showed only that a disputed <span CLASS="page_no" data-cite="2012 bl 254593 p 25" data-cite-type="Bloomberg" data-cite-pageno="25" data-primary-citation="">[**25]</span> recordkeeping requirement "might increase the
cost of some abortions by a slight amount." <i>Id.</i> The Court declined to find
an undue burden. The <i>Casey</i> Court also considered an in-person
informed-consent requirement and a twenty-four hour notification
requirement. <i>Casey</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=505%20us%20833&amp;summary=yes#jcite">505 U.S. at 884</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=112%20supreme%20court%202791&amp;summary=yes#jcite">112 S.Ct. 2791</a>. These requirements
caused women to make more trips to the clinic. The Court stated the facts on
the record as follows:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      The findings of fact . . . indicate that because of the distances
    many women must travel to reach an abortion provider, the practical
    effect will often be a delay of much more than a day because the
    waiting period requires that a woman seeking an abortion make at
    least two visits to the doctor. [I]n many instances this will
    increase the exposure of women seeking abortions to "the harassment
    and hostility of anti-abortion protestors demonstrating outside a
    clinic." As a result, . . . for those women who have the fewest
    financial resources, those who must travel long distances, and those
    who have difficulty explaining their whereabouts to husbands,
    employers, or others, the 24-hour waiting period will be
    "particularly burdensome."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i>Casey</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=505%20us%20833&amp;summary=yes#jcite">505 U.S. at 885-86</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=112%20supreme%20court%202791&amp;summary=yes#jcite">112 S.Ct. 2791</a>. Still, the Court found that even
these onerous impediments did not constitute an undue burden based on the
record.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In <i>Women's Med. Prof. Corp. v. Baird</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=438%20f%203d%20595&amp;summary=yes#jcite">438 F.3d 595</a> (6th Cir.2006), this
Court addressed the closure of a clinic, which required women to travel
farther for an abortion &mdash; giving rise to increased cost. The increased
travel distance caused by the disputed closing of a clinic in that case
would require women to travel at least 55 miles to reach an abortion clinic.
<i>Id.</i> at 605. After noting that the binding and persuasive authority did not
"firmly establish when distance becomes an undue burden" this Court found no
undue burden even though closing the clinic "may be burdensome" for some
potential patients. <i>Id.</i> This Court reasoned that there was no undue burden
because "there is no indication that the closing of the clinic would create
a substantial obstacle for Dayton-area women seeking an abortion" <i>Id.</i> at
606.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Similarly here, Planned Parenthood has not placed on the record any
evidence suggesting that the added cost of a medical abortion would unduly
burden the right to choose abortion for a large fraction of affected women.
Moreover, the evidence submitted by Planned Parenthood shows that surgical
abortion remains available at a lower price. In fact, the only woman who
mentioned the increased cost in her statement specifically said that this
would make it difficult for her to choose <i>medical</i> abortion, but not that it
would be a burden on her choice to abort her pregnancy. This evidence does
not give rise to a reasonable inference that the dosage increase is a
substantial obstacle to the choice to undergo abortion.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Even more than in the method-ban analysis, we cannot infer a substantial
obstacle from the evidence submitted regarding the increased dosage
requirement. The record arguably supports an inference that the increased
cost would burden women's ability to choose medical abortion, which may be
their preferred method. <span CLASS="page_no" data-cite="2012 bl 254593 p 26" data-cite-type="Bloomberg" data-cite-pageno="26" data-primary-citation="">[**26]</span> However, that does not permit a reasonable inference
that an undue burden on the constitutionally protected ."freedom to decide
whether to terminate" a pregnancy would result. <i>Casey</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=505%20us%20833&amp;summary=yes#jcite">505 U.S. at 874</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=112%20supreme%20court%202791&amp;summary=yes#jcite">112 S.Ct. 2791</a>. That is because, even
<span CLASS="page_no" data-cite="696 f 3d 518" data-cite-type="PrimaryFederalReporter" data-cite-pageno="518" data-primary-citation="696 F.3d 490">[*518]</span> 
assuming the increased cost presents a substantial obstacle to choosing a
medical abortion, women would still have the lower-priced option of surgical
abortion available to them. Without evidence that the cost increase would
create a substantial obstacle to the ultimate choice to undergo an abortion,
this claim cannot survive summary judgment.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Thus, the district court properly granted summary judgment on this claim
as well.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn101" name="fn101">[fn1]</a></span> Judge Moore refers to this conclusion as "resolving these fact
questions," and "conclusively establishing as a matter of law that the
method ban in this case does not impose a substantial obstacle. . . ." <i>See</i>
<i>ante</i> at &para;&para; 57, 63. Not at all. Instead, on the record before us and under
the summary judgment standard, Planned Parenthood did not sustain its burden
of adducing enough evidence to create a genuine question of fact. For an
issue of fact to be genuine, the nonmovant must do more than simply show
that there is some metaphysical doubt as to the material facts. <i>Matsushita</i>
<i>Elec. Indus. Co., Ltd. v. Zenith Radio Corp.</i>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=475%20us%20574&amp;summary=yes#jcite">475 U.S. 574</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=475%20us%20574&amp;summary=yes#jcite">586-587</a>,
<a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=106%20supreme%20court%201348&amp;summary=yes#jcite">106 S.Ct. 1348</a>, <a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/1?citation=89%20l%20ed%202d%20538&amp;summary=yes#jcite">89 L.Ed.2d 538</a> (1986). Planned Parenthood has not carried
its burden in this case.
</p></div>
<!--BBLS DD 1737463562243-->

</div>
<div class='sideBar printHide clearfix '>
<!-- /Default state -->
<!-- /Display properties -->
<div class='tabsNotepad printHide'>
<div class='tabButtons clearfix'>
<div class='borderTab activeTab' id='buttonTab_general'>
<span>
General Info
</span>
</div>
<div class='borderTab inactiveTab' id='buttonTab_notePad'>
<span>Notepad</span>
</div>
</div>
</div>
<div class='sideBarInner clearfix'>
<div class='sideBarContent bootstrap sidebar ' id='tab_general'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span class='left'>BCite Analysis</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider bciteRenderer clearfix'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1II4EC003/history">Direct History (10)</a>
</div>
<div class='sidebarItemLabel bold'>
No Negative Direct History
</div>
</div>
<div class='bciteRenderer clearfix sidebarSectionDivider sidebarSubsection'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1II4EC003/analysis">Case Analysis (7)</a>
</div>
<div class='bciteResult'>
<img class='icon printOnly' src='/images/citation_icons/positive.png'>
<div class='citation icon positive printHide' title='Positive'></div>
<a class='citationAnalysisLabel' href='/bcite/X1II4EC003/analysis?analysis=BCITE_POSITIVE_GROUP'>
Positive
</a>
<span class='citationNumberLabel'>
6
</span>
</div>
<div class='bciteResult'>
<img class='icon printOnly' src='/images/citation_icons/distinguished.png'>
<div class='citation distinguished icon printHide' title='Distinguished'></div>
<a class='citationAnalysisLabel' href='/bcite/X1II4EC003/analysis?analysis=distinguished'>
Distinguished
</a>
<span class='citationNumberLabel'>
1
</span>
</div>
</div>
<div class='sidebarSubsection clearfix analysisLink'>
<div class='sidebarSubhead small'>
<a href="https://www.bloomberglaw.com/help/BCite_Indicators.htm" class="citatorRenderer">Description of BCite Indicators</a>
</div>
</div>

<div id='generalInfo'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span>
General Information
</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Result(s)</div><div class='facetItemLabel'>Judgment Affirmed</div></div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Related Docket(s)</div><div class='facetItemLabel'><a href="/s/opinion/27097952869057ce1f291791b8f3f48d/document/X1Q6M1JUERO2">11-04062 (6th Cir.)</a></div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Topic(s)</div><div class='facetItemLabel'>Civil Procedure</div><div class='facetItemLabel'>Constitutional Law</div></div>
<div class='sidebarSubsection' id='judges_section'>
<div class='facetItemHeading'>Judge(s)</div>
<div id='judges_section_loader'></div>
</div>
</div>
</div>
</div>
</div>
<div class='sideBarContent clearfix notepad hidden' id='tab_notePad'>
<div id='notepad'>
<div class='notepadInstructions'>
Click anywhere in Notepad to add a note.
</div>
<div class='protoNote note'>
<a class='anchor'></a>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
<div class='ieFloat right'>
<a class='delete'>
Delete
</a>
<div class='toolDivider'>
|
</div>
<a class='edit'>
Edit
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='body'></div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay'></span>
</div>
<div class='ieFloat right'>
<a class='next'>
Next
</a>
</div>
</div>
</div>
<div class='protoNoteEditor note'>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
</div>
<div class='body'>
<textarea class='contents'></textarea>
<div class='toolRow'>
<a class='save'>
Save
</a>
<div class='toolDivider'>
|
</div>
<a class='cancel'>
Cancel
</a>
<div class='clearfix'></div>
</div>
</div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous disabled'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay disabled'></span>
</div>
<div class='ieFloat right'>
<a class='next disabled'>
Next
</a>
</div>
</div>
</div>
<div class='protoConfirmDelete'>
<div class='popupWindowOuter'>
<div class='popupWindowInner'>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>
Delete Note
</h2>
</div>
<div class='popupContent'>
<div class='sectionLabel'>
Are you sure you want to delete this note?
<br>
<br>
<br>
<br>
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right'>
<span>
Delete
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup()'>
<span>
Cancel
</span>
</button>
</div>
</div>
</div>
</div>
</div>

</div>
</div>

</div>
<div class='clearfix'></div>
</div>

<div class='keywordSearch' id='keyword_search'>
<a href="javascript:Blaw__findPrevKeyWord();redrawPrevNextButtons();" id="keyword_search_previous">Previous Keyword</a>
|
<a href="javascript:Blaw__findNextKeyWord();redrawPrevNextButtons();" id="keyword_search_next">Next Keyword</a>
</div>
<div class='pageLoader'></div>
<div class='browserPopupContainer' id='browserPopup'>
<div class='browserTitle'>
<div class='close' onclick='$("#browserPopup").bbTocBrowser(false);'></div>
<h2 class='popup_title'></h2>
</div>
<div class='browserPopupContent popup_content' id='browserPopupContent'></div>
</div>
<div class='maskOverlay' id='ajax_browser_mask'></div>


<div class='clearfix'></div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->
<div class='clientMatterContainer hidden' id='clientMatterContainer'>
<form accept-charset="UTF-8" action="/client_matter/session/create" id="startClientMatterSessionForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id="create_client_matter" name="create_client_matter" type="hidden" value="false" />
<div class='clearfix popupTitle'>
<div class='close' onclick='cancelClientMatterPopup()'></div>
<h2>
Enter a Client Matter
</h2>
</div>
<div class='popUpContent'>
<div class='clientMatterPopupHeader'>
Your firm optionally allows a client matter to be selected while you are using Bloomberg Law.
Please select from a recently used Client Matter or enter a Client Matter manually.
</div>
<div class='error' id='clientMatterLabelErrors' style='display:none'></div>
<div class='error' id='attorneyNumberLabelErrors' style='display:none'></div>
<div class='row sources clearfix'>
<div class='labelHolder'>
<span class='label'>Client Matter</span>
</div>
<div class='inputContainer'>
<input autocomplete="off" class="autocompleteTextField input_auto autocompleteForm" data-context="CLIENT_MATTERS" data-highlight-term="true" data-select-callback="applyClientMatterFromAutocompleteSelection" data-show-no-matches="false" data-url="/autocomplete/lookup" id="client_matter_label" name="client_matter_label" type="text" value="" />
<script type="text/javascript">
//<![CDATA[
jQuery().ready(function ($) { $('#client_matter_label').bbAutocomplete(); });
//]]>
</script>
</div>
</div>
<div class='row clientMatterSuppressionCheckholder' id='clientMatterSuppressionCheckholder'>
<label>
<input id="suppress_client_matter_prompt_enabled" name="suppress_client_matter_prompt_enabled" type="hidden" value="1" />
<input checked="checked" id="suppress_client_matter_prompt" name="suppress_client_matter_prompt" type="checkbox" value="1" />
<label for="suppress_client_matter_prompt">Do not remind me again this session</label>
</label>
</div>
<div class='clientMatterText'>
Please contact your administrator if you have questions about client matter.
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup right' type='submit'>
<span>
Submit
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='cancelClientMatterPopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

<div id='createClientMatterForm' style='display:none'>
<div class='clearfix popupTitle'>
<h2>
Unrecognized Client Matter
</h2>
</div>
<div class='div'>
Client Matter
<span id='new_client_matter_label'>&nbsp;</span>
does not currently exist in Bloomberg Law. Would you like to add this client matter to the system?
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' type='button'>
<span>
Yes
</span>
</button>
<button class='bootstrap skinButton popup cancel right' type='button'>
<span>
No
</span>
</button>
</div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->

<div id='loading_container'></div>
<div class='fixedControls menuHolder printHide' id='bottom_menu_row'>
<div class='menuButton' id='pde_tray_menu'>
<div class='queueImageHolder'></div>
<div class='indicator num_of_pde_tray_items'></div>
</div>
<div class='clearfix'></div>
</div>
<div class='menuItem bottomMenu' id='pde_tray'>
<div class='inner'>
<div class='heading'>
<div class='title'>
Queue
<span class='indicator num_of_pde_tray_items'></span>
<!-- =pde_tray_count_from_session -->
</div>
<div class='bootstrap closeIcon right' id='pde_tray_close_button'></div>
<div class='clearfix'></div>
</div>
<div class='actions hasItems' id='pde_tray_has_items'>
<div class='selection'>
<div class='trayCheckHolder'>
<input id='pde_tray_select_all' type='checkbox'>
</div>
Select All
</div>
<div class='tools'>
<a onclick='javascript:PDETray_default.downloadSelection();'>
Print/Download
</a>
|
<a onclick='javascript:PDETray_default.emailSelection();'>
Email
</a>
|
<a onclick='javascript:PDETray_default.workspaceSelection();'>
+ Workspace
</a>
|
<a onclick='javascript:PDETray_default.deleteSelection();'>
Delete
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='actions noItems' id='pde_tray_no_items'>
<div class='title'>
You have no items in your Queue
</div>
<div class='clearfix'></div>
</div>
<div class='itemsHolder' id='pde_tray_items'></div>
</div>
</div>

<div class='maskOverlay' id='pde_tray_mask'></div>

<script language='javascript'>
var SHOW_AUDIT = false;
var ROOT_PATH = "/";
var RAILS_ROOT = "/";
var CONTEXT_PATH = "/";
var DOC_ROOT_PATH = "/s/opinion/27097952869057ce1f291791b8f3f48d/";
var RESULTS_ROOT_PATH = "/search/results/";
var SELECTED_CONTEXT = "";
var MODULE_PATH;
MODULE_PATH = "/document";
var CRUMB_ID = "27097952869057ce1f291791b8f3f48d";
var BILLING_CONFIGURATION = {"DOCKET":true,"NEWS":false,"LAW":true,"ADVANCED_LEGAL":true,"PATENT":true,"PATENT_ASSIGNMENT":true,"PEOPLE":false,"OPINION":true,"CITATION":false,"BREAKING":true,"DOCKET_REQUESTS":true,"COMPANY_FILINGS_EDGAR":false,"COMPANY_FILINGS_DOCKETS":false,"COMPANY_FILINGS_OTHER":false,"CORP_ACTIONS":true,"ECO_SEARCH":true,"EDGAR_SEARCH":true,"EXAMPLE_DOCUMENTS":true,"CLAUSE_SEARCH":true,"LEG":true,"REG":true,"BOOLEAN":false,"SIMPLE":false,"COMPANY_DOCKETS":true,"TOC_SEARCH":true,"IMMUTABLE_LAW_SEARCH":true};
var CONTEXT_BILLING_POLICY_KEY = "";
var ELITE_ENABLED = false;
var CLIENT_MATTER_PROMPT_ENABLED = false;
var CLIENT_MATTER_ON_LOGIN_ENABLED = false;
var SUPPRESS_CLIENT_MATTER_PROMPT = false;
var clientMatterActive = false;
var currentClientMatter = '';
var currentAttorneyNumber = '';
var clientMatterHaltedForm = null;
var USER_ID = 'un=373038066';
var SESSION_ID = '63166_a5929cc15e1bfd637ed52768bec5d196';
var NTPT_REDIRECTED_EVENT = '';
var NTPT_PGEXTRA = '&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITYf2b98c&previousPageId=&previousActivityInstanceId=ENTITY0c7259&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T07:25:01-05:00';
var NTPT_GLBLEXTRA = 'un=373038066&sessionId=63166_a5929cc15e1bfd637ed52768bec5d196&auth=true';
var BROWSER_COMPATIBILITY_WARNING = 'false';
var SHOW_MODAL = false;
var JUG;
$(document).ready(function(){
setTimeout(framework_getPageState,500);
framework_bindGlobalResizeElements();
notepad_onDocumentLoaded();
<!-- /DRQS 24932463 -->
$("#downloadPopupLinkForm a").removeAttr("href");
$('#startClientMatterSessionForm').submit(function() {
  createClientMatterSessionFromForm(this);
  return false;
});

var t = $('.clientMattersTableEl');

jQuery.each(t, function(name, value) {
  try {
    var this_value =  $.trim(String(value.innerHTML));
    var this_final_value = this_value.length > 22 ? this_value.substring(0,9)+"..." : this_value;
    value.innerHTML = this_final_value;
  } catch (e) {}
});

$('#startClientMatterSessionForm .recentlyUsed td').click(function() {
  $('#client_matter_label').val($.trim($(this).attr("title")));
});

});
</script>
<script type='text/javascript'>
DOCUMENT_SHOW_SIDEBAR="true";
DOCUMENT_HAS_SIDEBAR_INFO="true";
DOCUMENT_IS_IFRAME="";
NTPT_PGEXTRA = 'documentSearchType=OPINION&docId=X1II4EC003&docType=OPINIONS&contentClass=LEGAL&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY0c7259&previousPageId=&previousActivityInstanceId=ENTITYa5c3b0&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T07:24:59-05:00';
FLUID_LAYOUT="false";
FULL_DOC_ID = 'X1II4EC003';
NOTEPAD_UUID="11082191";
NOTEPAD_DOC_ID="X1II4EC003";
$('#page_loader').show().spin();
JUDGE_IDS=["1840872","3028396","6270816"];
JUDGE_NAMES=null;
</script>

<script src="/javascripts/activity_tracking/ni.js?1376494218" type="text/javascript"></script>
<script src="/javascripts/activity_tracking/tracking.js?1384975732" type="text/javascript"></script>
<div class='footer'>
<div class='footerContent printHide'>
<div class='logoContainer grid eight'>
<div class='copyright'>
&copy; 2014 The Bureau of National Affairs, Inc. All Rights Reserved.
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPR08'); return false;">Terms of Service</a>
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPH08'); return false;">Privacy Policy</a>
</div>
<a class='logo' href='/home'></a>
<div class='version'>
2.
231154
Gem
0.176.7
231497
 - 3.0.20
</div>
<div class='helpContainer'>
<div class='helpDesk'></div>
<a href="/help/BLAWHelpSystem.htm#Contact_Us.htm" class="menuLink">Submit Feedback</a>
 | 
<a href="mailto:blawhelp@bna.com" class="menuLink">blawhelp@bna.com</a>
</div>
</div>
</div>

</div>
</div>
</body>
</html>
